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ABSTRACT 
Eukaryotic DNA and histone proteins are packaged into chromatin that can occur 
in two cytologically distinct states: heterochromatin, which is highly compacted and 
transcriptionally repressive; or euchromatin, which is relatively open and 
transcriptionally permissive. Increasing experimental evidence suggest that the structure 
and function of chromatin is governed, in part, by histone post-translational modifications 
(PTMs), but their characterization is generally protracted because of the biological 
complexities associated with higher eukaryotes. Moreover, recent studies have shown 
that euchromatin and heterochromatin represent the extremes of a continuum of 
physiological chromatin states, which may be encoded for by distinct combinations of 
histone PTMs. These states also have transcription-independent roles during interphase, 
mitosis, and meiosis that contribute to, among other activities, maintaining genomic 
stability. 
 To screen for novel heterochromatin associated histone PTMs, we took advantage 
of the nuclear dimorphism afforded by the single-celled ciliate Tetrahymena thermophila. 
This model organism has two physically separable nuclei with its cytoplasm: a 
heterochromatic micronucleus (germline genome), and a euchromatic macronucleus 
(somatic genome). In this dissertation, I present our work identifying and characterizing 
histone H3 lysine 23 methylation (H3K23me) in the micronucleus. We report that H3K23 
trimethylation (H3K23me3) is a micronucleus-specific heterochromatin modification that 
becomes particularly enriched during meiosis. Loss of H3K23me3, through deletion of its 
putative methyltransferase Ezl3p, causes mislocalization of meiosis-induced DNA 
double-strand breaks to heterochromatin, and decreases progeny viability. We extend the 
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significance of H3K23me3 to higher eukaryotes by showing its meiotic upregulation is 
conserved in germlines of C. elegans and mice. In summary, our results suggest that the 
evolutionary conserved H3K23me3 plays an important role in protecting meiotic, 
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CHAPTER 1: GENERAL INTRODUCTION 
 
1.1   EPIGENETICS AND CHROMATIN 
 A single human body contains roughly 250 distinct cell types, each virtually 
having the same DNA code.1 Moreover, all human cell types are derived from a single, 
fertilized egg that after just two divisions produces four isogenic daughter cells with 
unique developmental trajectories.2, 3 Understanding how multiple phenotypes arise from 
a single genome remains a central problem in biology and genetics.  
 In 1942, Conrad Waddington coined the term epigenetics to relate genes and gene 
products to development. A modern definition of epigenetics emerged in 1975, when two 
independent groups proposed that patterns of DNA methylation, a chemical modification 
of the cytosine-guanine dinucleotide (CpG), could affect gene expression and be inherited 
during cell division.4, 5 Since then, epigenetics has been defined as the study of heritable 
changes in gene expression that are not caused by changes in DNA sequence. In addition 
to DNA methylation, the epigenome now includes histone proteins and their post-
translational modifications, as well as several other factors such as non-coding RNA.6   
  Many decades before the modern definition of epigenetics took shape, its cellular 
basis was coming to light from cytological studies of eukaryotic DNA. Defined as the 
physiological form of the eukaryotic genome, chromatin is made up of DNA and histone 
proteins, as well as other proteins with chromatin modifying activities. Using dyes, Emil 
Heitz discovered in 1928 that chromatin can exist in structurally dense and loose forms, 
and he designated these regions as heterochromatin and euchromatin, respectively.7 
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Furthermore, he found that heterochromatin remains tightly packed throughout the entire 
cell cycle and, therefore, suggested that the underlying DNA was physically inaccessible 
and functionally inert. He supported this hypothesis by showing that heterochromatic 
DNA is deficient in genes.8 Teleologically, these early studies suggested that chromatin 
structure could regulate gene transcription and other DNA-templated processes by 
controlling direct access to regulatory DNA elements (e.g. promoters and enhancers).  
 
1.2   THE NUCLEOSOME AND HISTONES 
 While the existence of histones have been recognized since the late 19th century, it 
wasn’t until the 1960s and 1970s that a molecular view chromatin began to unravel. In 
this period, several studies systematically uncovered the highly organized and structurally 
repetitive nature of the chromatin fiber.9-12 Prompted by electron micrographs of highly 
purified chromatin strands, a model was proposed that likened the basic structure of 
chromatin to beads on a string.13, 14 Early work revealed that each repetitive unit, called a 
nucleosome, is composed of histone proteins and around 200 base pairs (bp) of DNA.15  
Later, micrococcal nucleus digestions of chromatin identified the linker (~50 bp of DNA) 
and core particle (‘bead’; ~150 bp of DNA and histones) regions of the nucleosome.15  
The structural dissection of nucleosomes finally culminated in 1997 with the x-ray 
crystallographic image of the core particle described by Luger et al.16 The data revealed 
that roughly 146 bp of DNA wrap around (~1.7 turns) an octamer core of histone proteins 
containing two copies of the canonical histones H2A, H2B, H4, and H3 (Figure 1). This 
structure not only provided an atomic view of how DNA is neatly packaged under 
physiological conditions, but it also provided the basis for the succeeding functional  
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studies of histones and their post-translational modifications.  
The histone superfamily is categorized into two groups of highly conserved 
histone proteins: the linker histones and the core histones. Because they bind to the linker 
DNA region of nucleosomes, histone H1 and its variants constitute the linker histone 
group. Linker histones primarily play a structural role in chromatin, acting to form 
higher-ordered states of compaction. Furthermore, studies have shown that linker 
histones are enriched in heterochromatic regions of the genome and directly contribute to 
transcriptional silencing.17, 18 The other group of histones contains the canonical histones 
and their many variants that make up the core particle of the nucleosome. While each of 
the core histones have distinct properties, collectively they contribute to processes 
involving genomic DNA (e.g. replication, transcription, and repair) and ultimately help to 
maintain genomic organization and stability.19 In all, there are five major histones (H1, 
H2A, H2B, H4, and H3) and numerous minor variants within the human genome. These 
variants are less conserved, but they have specialized properties that help diversify 
chromatin function and structure. 
  
1.3   HISTONE POST-TRANSLATIONAL MODIFICATIONS 
 In addition to the specific interactions between DNA and histone polypeptides 
within the nucleosome core, the crystal structure by Luger et al. showed that histone N-
terminal tails extend beyond the nucleosome, interact with DNA on the outer portion of 
the nucleosome, and are relatively unstructured (Figure 1, arrow).16 This view suggested 
a functional role for histone tails, whose positively charged lysines and arginines closely 
interacted with the negatively charged backbone of DNA. Additionally, the unstructured 
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nature of the tails allowed for their extension beyond the nucleosome and exposure to 
nucleoplasmic proteins. Conforming to this paradigm, histone tails, particularly those of 
histone H3, are abundantly and dynamically modified with distinct types of PTMs 
(Figure 2).20 Anecdotally, most common types of PTMs have been detected on histones, 
and almost every nucleophilic center on the H3 tail has been modified in some cellular 
context.  
The most well characterized classes of PTMs include acetylation, 
phosphorylation, and methylation.20 As discussed below, histone PTMs are dynamically 
regulated by the balancing activities of enzymes that catalyze the addition of marks 
(writers) and their removal (erasers). How histone PTMs encode for biological outputs is 
not entirely understood, but there is a growing number of known effector proteins with 
chromatin modifying activities that can bind (read) specific types and combinations of 
histone PTMs. Their reader functions are also largely dependent on the position of PTMs 
on histone tails.21 Therefore, specific combinations of histone PTMs have been proposed 
to constitute a “histone code” or signature that encode for distinct functional outputs.22-24  
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1.3A   LYSINE ACETYLATION 
 It has long been established that acetylation of lysines on histone tails neutralizes 
the positive charge on the ε-amino group and lowers the affinity of histones for DNA.11, 25  
Coupled with the insights from the Luger et al. nucleosome structure, these observations 
supported a model wherein dynamic acetylation of histone tails leads to the loosening of 
chromatin structure, facilitating histone eviction, transcription factor binding and gene 
transcription by RNA polymerase II.26-28 Several lines of evidence have amassed that 
functionally link histone acetylation and gene activity. Some of the early examples 
include a seminal study showing that histones are largely devoid of acetylation in the 
transcriptionally inactive X chromosome and pericentric heterochromatin of mammals.29  
Another study found that antibodies raised against chemically acetylated histone H4 
highly co-purify with chromatin containing the transcriptionally active gene, alpha D 
globin.30 Although histone acetylation has strong ties to transcription, several studies 
have shown that acetylation alone is not sufficient to induce transcription.31 For example, 
a recent study showed that pharmacological inhibition of histone deacetylase 3 (HDAC3) 
causes hyperacetylation, but not transcriptional activation, of target genes.32 In addition to 
chromatin dynamics and transcription activity, histone acetylation is also involved in 
replication dependent and independent nucleosome assembly and histone deposition 
pathways.33, 34   
 As gene transcription states can range from ‘on’ to ‘off’ depending on 
environmental or developmental cues, it stands to reason that local histone acetylation is 
also reversibly regulated. This realization fueled the search for enzymes that catalyzed 
the acetylation and deacetylation of histones. The long awaited nuclear histone 
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acetyltransferase (HAT) was reported in 1996.35 This nuclear HAT was identified in the 
model organism, Tetrahymena thermophila, and found to be a homolog of the yeast 
GCN5 protein, previously shown to be a transcriptional co-activator.36 Coincidentally, 
another study found that the yeast Rap5 protein (a known repressor of transcription) has 
histone deacetylase (HDAC) activity.37 The discovery of HATs and HDACs marked a 
key point in the field of epigenetics, as it provided a critical link between chromatin 
structure and transcriptional regulation.38  
 Although histone modifications, such as acetylation, can have direct effects on 
histone and chromatin function by virtue of their chemical properties, a wealth of 
structural and functional data now show that chromatin-associated proteins contain 
subdomains that can bind to their cognate histone PTM.21 These findings represent a new 
mechanism of protein-protein interactions regulated by histone PTMs. The first histone 
PTM binding domain to be structurally characterized was the bromodomain, which was 
proposed to bind to acetyllysine.39 Subsequent studies solidified the role of the 
evolutionary conserved bromodomain as a reader of acetylated histones.40   
 
1.3B    SERINE/THREONINE PHOSPHORYLATION 
 All core histones contain Serine/Threonine/Tyrosine amino acids that can be 
phosphorylated by kinases and dephosphorylated by phosphatases. Depending on the site, 
histone phosphorylation can either be involved in transcription, cellular division, or DNA 
damage recognition and repair.41 Several proteins such as 14-3-3 and MDC (via the 
BRCT domain) have been shown to engage chromatin by binding to histones in a 
phosphorylation dependent manner.21, 42 Like acetylation, phosphorylation neutralizes the 
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net positive charge of histone tails, although its effect on higher ordered chromatin 
packaging changes depending on the cell cycle and therefore is more complex than the 
effect of acetylation. There are at least 20 different sites known to be phosphorylated in 
core histones (see Rossetto et al.41  for a detailed review), but here I will focus on two 
major sites that are relevant to this dissertation.  
 Phosphorylation of histone H3 serine 10 (H3S10ph) is an important and highly 
conserved modification that plays a role in chromosome condensation prior to mitosis. 
Although the mechanism is not clear, loss of H3S10ph leads to genomic instability and 
problems with segregation during mitosis.43 H3S10ph also represents a wonderful 
example of the combinatorial crosstalk of histone PTMs occurring in cis. It was shown 
that heterochromatin protein 1 (HP1), which reads histone H3 lysine 9 methylation 
(described below), is extruded from chromatin if the flanking H3S10 is phosphorylated 
during mitosis.44 As H3S10 is highly conserved across eukaryotic evolution, 
hyperphosphorylation of this site has generally been linked to mitosis in a wide range of 
organisms.45 Notwithstanding, the presence of this mark during interphase has also been 
linked to transcriptional activation.41, 44, 45   
 Another well-known histone phosphorylation event occurs on the extended C-
terminal tail of the variant H2A.X. This region is lacking in the canonical histone H2A. 
Specifically, the modification occurs on S139 in mammals and S129 in yeast, and is 
commonly referred to as γH2A.X. This modification is crucial for the recognition and 
repair signaling of DNA double-strand breaks (DSBs) that can be caused by exogenous 
agents, stalled replication forks, or meiotic recombination events.46 Mice completely 
lacking the H2A.X gene contain unstable genomes that lead to infertility, growth 
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retardation, and increased sensitivity to radiation.47 In line with these results, non-
phosphorylatable mutations of S129 in budding yeast leads to hypersensitivity to 
chemically induced DSBs.48, 49   
γH2A.X initiates directly next to DSBs and spreads in both directions over 
megabase pair regions in higher eukaryotes.50-53 This spreading is thought to create a 
regulatory scaffold that integrates and recruits the activities of several cell cycle 
checkpoint and DNA repair protein complexes. One such protein is MDC1, which binds 
to γH2A.X directly through its BRCT domain.42 As DSBs are especially toxic to cells and 
are associated with ageing and chemotoxicity, detecting them using antibodies against 
γH2A.X has had great clinical value.54 Aside from disease states, γH2A.X is also present 
in meiotic germ cells, when massive amounts of programmed DSBs are catalyzed by the 
evolutionary conserved Spoll endonuclease to facilitate homolog pairing and DNA 
recombination. Details of the dynamics of γH2A.X in meiotic cells are described below 
in Chapter 4.  
 
1.3C   LYSINE METHYLATION 
 Whereas acetylation and phosphorylation primarily affect charge-based 
properties, methylation confers hydrophobic character to the positively charged lysines of 
histone tails. Adding to the complexity of methylation, lysines can be mono-, di-, or tri-
methylated, and increasing experimental evidence show that each methylation state can 
be associated with different biological readouts. Indeed, it has been shown that several 
histone PTM readers can distinguish among methylation states of lysines.21, 55 These 
readers not only contain cognate pockets that specifically interact with the PTMs, but can 
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also interact with regions flanking the modified amino acid (typically ±5 amino acids), 
underscoring the importance of the position of methylated lysines within polypeptides.21  
Genome-wide analyses have shown that methylation can be associated with either 
transcriptional activation or repression, depending on the position and extent of the 
methyl mark. As with most other histone PTMs, histone methylation is kept in balance 
with the opposing activities of lysine methyltransferases and demethylases. Within this 
context, the most diversely and dynamically methylated histone isoform is histone H3. 
The three major and most well characterized sites of methylation on H3 are lysines 4, 9, 
and 27, with each being involved in fundamentally different chromatin associated 
processes.  
 Methylation on H3K4 is a highly conserved chromatin marked correlated with 
euchromatin and active transcription.56, 57 This mark is catalyzed by trithorax group 
proteins, including TRX in Drosophila, Set1p in S. cerevisiae, and myeloid or mixed 
lineage leukemia (MLL) in mammals.58 H3K4 methylation, in particular trimethylation, 
positively regulates transcription by recruiting HATs and nucleosome remodeling 
enzymes to transcriptional start sites.59 In light of these findings, it is especially 
surprising that yeast lacking Set1p (and therefore H3K4 methylation) are viable.60  
Nevertheless, this strain expresses growth defects  and defective transcriptional silencing 
of the mating-type locus and telomeres. Thus, although H3K4 methylation is not required 
for viability in yeast, deposition of this mark is obligatory for maintaining chromatin 
homeostasis and achieving proper gene expression programs.  
 H3K9 methylation and H3K27 methylation are conserved PTMs involved in the 
formation and maintenance of heterochromatin. Despite their general association with 
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heterochromatin, it is becoming increasing clear that they contribute to a growing number 
of distinct biological mechanisms of transcriptional silencing. Indeed, H3K9me3 is 
enriched in constitutive heterochromatin, which is found at structural or highly repetitive 
stretches of the genome. Alternatively, H3K27me3 is enriched in facultative 
heterochromatin, which can be dynamically activated or silenced depending on 
developmental or environmental cues. A detailed description of the properties of H3K9 
and H3K27methylation is presented below. 
 
1.4   TYPES OF HETEROCHROMATIN 
 
1.4A   HISTONE H3 LYSINE 9 METHYLATION AND CONSTITUTIVE HETEROCHROMATIN 
 While heterochromatin was originally described as intensely stained parts of 
chromosomes, studies of H3K9 methylation and H3K27 methylation have helped 
uncover different varieties or sub-domains of condensed chromatin.22, 27 Constitutive 
heterochromatin is found at structural or highly repetitive stretches of the genome like 
pericentric or subtelomeric regions, is enriched in Su(var) (suppressors of position effect 
variegation) proteins and H3K9me3.61-64 The biological activities of H3K9 methylation 
are largely dependent on the methyl status of H3K9, which is regulated by a large number 
of putative mono-, di-, and tri-methyl H3K9 writers in the human genome.65, 66  
 Monomethylation of H3K9 has been biologically linked to the stability and 
deposition of H3K9me3.67, 68 In this way, multi-step deposition of methyl groups on 
H3K9 by distinct writers could function to tightly regulate constitutive heterochromatin 
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formation. However, the roles of H3K9me1 do not entirely overlap with H3K9me3-
associated biology. In fact, the subnuclear localization and regulation of H3K9me1 can 
be very distinct from those of H3K9me3 during development and cell growth.65  
Therefore, a comprehensive description of the biological activity of H3K9me1 is 
currently lacking, but in general terms it is a histone PTM associated with constitutive 
heterochromatin.  
 A confounding factor in assessing the biological significance of H3K9me1, is that 
its major writer, G9a, is also the major writer for H3K9me2, which increasing 
experimental data suggest is principally involved with the maintenance of 
heterochromatin at the nuclear periphery.68-70 Compartmentalization of chromatin to the 
nuclear periphery is a major gene-silencing pathway during stem cell differentiation.71 
The nuclear periphery can also house gene-poor DNA such as centromeres and 
telomeres.72, 73 The role of H3K9me2 appears to be uniquely different from those of 
H3K9me1 and H3K9me3, as its deposition and regulation primarily affects gene 
expression profiles rather than silencing of gene-poor DNA.70, 73 The mechanisms of 
large-scale localization of chromatin to the nuclear periphery are multifaceted and 
unclear, but H3K9me2 appears to play an important role in anchoring heterochromatin to 
the nuclear periphery.65, 67    
 Trimethylation of H3K9 is highly correlated with transcriptional silencing of 
pericentric, repetitive, and telomeric DNA. Three elegant studies in the early 2000s 
helped solidify the importance of H3K9me3 in the formation of constitutively silent 
heterochromatin. The first was a genetic and biochemical study in fission yeast that 
linked the activities of Clr4 (a homolog of Suv3-9h), a known K9 methyltransferase, and 
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a heterochromatin protein 1 (HP1) isoform, known to colocalize with heterochromatin in 
Drosophila, together with H3K9me3.61 The second was a structural and biochemical 
study of HP1 (via the chromodomain) binding to methylated H3K9 that showed the 
affinity of this interaction is in the low micromolar and physiologically relevant range.64  
Finally, a mouse study showed Su(var)3-9h is a H3K9 methyltransferase that targets 
H3K9me3 to pericentric heterochromatin and that its genetic disruption leads to genomic 
instability in somatic and germ cells.63  
 Curiously, HP1 isoforms can bind to H3K9me1/2/3 with similar affinities in 
vitro.55 How these HP1 binding properties relate to the diversity of H3K9 methylation-
related functions in the cells remain unknown, but the promiscuity of HP1 binding 
suggests the presence of higher levels of regulation in vivo. Notably, several recent 
studies have uncovered novel H3K9methyl readers, some of which are able to distinguish 
among different methylation states of H3K9.55, 74 These studies also showed that HP1 
isoforms can bind to mono-, di-, and tri-methylated H3K23 in vitro.55 Although the levels 
of this mark appear to be very low (<1%) in the cells lines used in the studies, these 
finding point to a potential cross-talk or cross-regulation of H3K9 and H3K23 
methylation. Intriguingly, H3K9 and H3K23 are flanked by a conserved KQXAXK9/23 
that may serve as the basis for some of the putative functional overlap of these residues.  
 
1.4B   HISTONE H3 LYSINE 27 METHYLATION AND FACULTATIVE HETEROCHROMATIN 
 Like constitutive heterochromatin, regions of facultative heterochromatin are also 
condensed; however, they are enriched in H3K27me3, and can become activated or 
silenced in response to different cellular environments. Much of what is known about 
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H3K27me3 is rooted in the early studies of Polycomb group proteins (PGP) in 
Drosophila. Long before it was shown that the PGP methyltransferase called Enhancer of 
Zeste (E[z]) writes H3K27me375 , several studies had linked this protein, together with 
several other genes, to the silencing of homeotic (Hox) genes in flies.76 In general, it was 
known that PGP activity directly antagonizes trithorax group proteins. Subsequent studies 
helped define two major protein complexes that carried out Polycomb group silencing: 
Polycomb repressive complex 1 (PRC1) and Polycomb repressive complex 2 (PRC2). 
PRC2 contains the H3K27me3 writer E(z) and at least three other proteins, including 
ESC, SU(Z)12, and NURF555 that that contribute in various ways to the activity of 
E(z).76 PRC1 is generally composed of the chromodomain-containing protein Polycomb 
(PC), as well as PH, PSC, and RING.77 PRC1 is targeted to chromatin via the specific 
interaction of the chromodomain of PC to H3K27me3.76 These complexes are highly 
conserved in other eukaryotic organisms including mice, humans, plants, and the single-
celled eukaryotes Tetrahymena thermophila. Moreover, PRCs occur in multiple versions 
(transient interactions or variants of the core proteins) that seem to have different 
activities in vivo.78   
 In mammals, the PGP silencing pathway is important for stem cell differentiation, 
X-chromosome inactivation in females, and cancer.76 Loss of E(z) family proteins, as 
well as other PRC members, leads to embryonic lethality in mice and Drosophila, and 
sterility in C. elegans.79-82 Genome-wide ChIP-seq studies have shown that H3K27me3, 
like H3K4me3, is primarily enriched in the nucleosome directly preceding the 
transcriptional start site of genes. Data from these studies confirm that H3K27me3 is 
highly correlated with silenced genes, whereas H3K4me3 is associated with actively 
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transcribed genes. Interestingly, both H3K4me3 and H3K27me3 can be detected in 
overlapping promoter nucleosomes of developmentally regulated genes in embryonic 
stems.83 These so-called ‘bivalent domains’ are thought to regulate gene expression 
programs during stem cell differentiation. Despite these exciting advancements, how PGP 
proteins suppress transcription and how they are targeted to specific genes during 
development is still not clear. With respect to the latter, there is increasing evidence that 
small RNAs, in addition to H3K27me3, play a critical role in the genomic localization of 
PRC2.84, 85  
 Almost all of the studies concerning PGP silencing have focused on H3K27me3. 
However, other histone marks are also involved and are perhaps regulated, or stimulated, 
by the presence of H3K27me3. The most well studied example is mono-ubiquitination of 
the C-terminal tail of H2A, which is carried out by the RING domain containing E3 
ligase protein present in PRC1.76, 86, 87 Because PRC1 is thought to be recruited to 
chromatin by its interaction with H3K27me3, it is formally possible that its ubiquitinating 
activities are also downstream of PRC2-mediated H3K27me3 deposition.76 However, 
several studies have shown that the deposition of these two modifications may be less co-
dependent than the above model would suggest.88, 89 Still, genome-wide studies have 
shown that there is significant overlap between H3K27me3 and H2A 
monoubiquitination, suggesting that they act coordinately to carry out PGP-mediated 
silencing. Consistent with their role in gene silencing, PRC2 activity and H3K27me3 
deposition have also been linked to histone deacetylation. This effect is accomplished by 
the transient interaction of HDACs with EED (a conserved member of PRC2) at 
chromatin. Strengthening the potential existence of crosstalk between H3K27me3 and 
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histone deacetylation, it was also shown that EED contains a subdomain that functions as 
a reader of H3K27me3.90   
 
1.5   THE BIOLOGICAL SIGNIFICANCE OF HISTONE PTMS  
 There is little doubt that certain histone PTMs mark distinct chromatin states, but 
their biological significance, and the existence of a strict ‘histone code,’ is currently 
under intense debate. The major point of contention converges on the issue of cause and 
effect. Namely, do histone PTMs underlie distinct chromatin states, or are they simply a 
consequence of the diverse processes associated with each type of chromatin? A myriad 
of studies have provided substantial data that collectively seem to support both 
viewpoints.  
 The histone code hypothesis states that specific combinations of histone PTMs 
encode distinct biological outcomes by recruiting reader proteins (or complexes) with 
chromatin modifying capabilities. This hypothesis stemmed in large part from the 
appreciation that histones are often multiply modified by specific PTM patterns within 
the same polypeptide and/or the same nucleosome (e.g. bivalent domains). This model is 
also reinforced by several studies showing that multiple histone PTMs are biochemically 
and genetically linked upstream of biological outputs. Moreover, chromatin associated 
proteins often contain multiple subdomains that can read specific classes of histone 
PTMs, underscoring their potential to engage chromatin through multivalent interactions 
with modified histones. Several studies have been published that provide in vivo and in 
vitro support for the multivalent character of chromatin associated proteins.91-94   
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 Alternatively, many argue that a “histone code” hypothesis is overly complex and 
the biological influence of histone PTMs is overstated in the literature. They propose 
instead that the DNA accessibility/nucleosome positioning paradigm can sufficiently 
explain the growing complexities of chromatin and that histone PTMs could serve as 
allosteric activators (instead of recruiters) of chromatin modifying enzymes. Some of 
their main arguments, articulated in two perspective articles 95, 96, are the following: 1) 
Although there are hundreds of histone PTMs, genome-wide ChIP-seq studies have 
shown that they significantly overlap in the genome, suggesting that the seemingly 
infinite combinations of histone PTM manifest only as a few modifications states in vivo; 
2) The presence of multiple binding modules within chromatin modifying proteins and 
complexes is irrelevant since most contain weak binding constants (i.e. ~100 uM) to their 
respective histone PTM and combining multiple histone PTMs in binding studies only 
yields modest increases in binding efficiency; 3) In the few studies where the data 
sufficiently supports multivalancy, the effects on transcription, or another chromatin 
function, are not entirely clear; 4) Loss of histone PTMs, either through mutation of the 
histone tail or deletion of a writer, is well-tolerated; and 5) In terms of histone 
acetylation, with the exception of H4K16, the position of the acetylation site (be it on 
histone H3 or histone H4) is negligible, instead the additive effect of the number of 
acetylations contributes to function. 
 Much of the arguments above are rooted in genetic and biochemical studies of 
yeast and genome-wide studies using ChIP-Chip or ChIP-seq. Although both study 
approaches have made a profound impact on the study of chromatin biology of higher 
eukaryotes, the data that they yield and their generalizability are not without any caveats. 
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Both S. cerevisiae and S. pombe chromatin are gene rich and relatively euchromatic 97, 
which does not recapitulate the complexity and the predominantly heterochromatic nature 
of higher eukaryotic chromatin. Even within the yeast clade, several profoundly distinct 
mechanisms of chromatin regulation have evolved. Take heterochromatin formation, for 
example, which is accomplished independently of known histone methylation sites in S. 
cerevisiae and almost exclusively with H3K9 methylation in S. pombe.98 Furthermore, 
both yeast strains lack H3K27 methylation, which severely limits their utility as model 
organisms to study the facultative heterochromatin present in higher eukaryotes. Within 
this context, it is formally possible that the DNA accessibility/nucleosome positioning 
paradigm is more dominant in yeast than in higher eukaryotes, and the consequences of 
disrupting histone PTMs in each organism are different.   
 The pitfalls of interpreting antibody- or chip- based histone PTM data sets are 
well documented.99 Namely, in a crowded landscape of histone PTMs, antibodies 
designed to recognize specific, singly modified epitopes on histone tails are often 
occluded by the other nearby PTMs. This causes a significant loss of information 
regarding the genomic localization of the histone PTM of interest. Moreover, most of the 
histone PTM antibodies developed and validated for ChIP are specific for methylation or 
acetylation, resulting in a dearth of information on the dozens of other histone PTM types 
known to occur in mammalian chromatin. Development of antibodies specific for 
multiply modified epitopes and other PTM classes will no doubt help resolve the 
molecular signatures associated with distinct chromatin states. Nevertheless, 
bioinformatic analyses utilizing the current data sets have already hinted at the existence 
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numerous chromatin states, which were demarcated by distinct combinations of histone 
PTMs and transcriptional states.  
 Central to this debate is the mechanism of epigenetic inheritance. Several studies 
have shown, from yeast to humans, that transcriptional programs can be inherited during 
the cell division. How is this information transmitted? To date, histone PTMs remain as 
the obvious mechanism underlying epigenetic memory and transmittance through mitosis 
or meiosis, although RNA seems to contribute as well in higher eukaryotes. Therefore, by 
inference, all epigenetic histone PTMs should have an inherent capability to signal for 
local chromatin remodeling in subsequent cell generations. Whether histone PTMs serve 
to recruit or allosterically activate chromatin-modifying pathways may be a rhetorical 
point given our limited, but growing, appreciation of the complexities of chromatin.100   
 
1.6   GOING BEYOND A CYTOLOGICAL VIEW OF CHROMATIN  
 The ENCylcopdieia Of DNA Elements (ENCODE) consortium recently 
published a series of papers that extensively described novel regulatory and functional 
elements of the human genome.101 Among its many discoveries, they concluded that 
roughly 75% of the human genome is amenable to transcription, and about half of the 
resulting RNAs have a ‘functional’ role in the cell.102 Although evidence of pervasive 
transcription has been previously reported in pilot, small scale studies of mammalian 
cells103, these ENCODE studies were genome-wide and were cross compared with 15 
different cell lines. Considering that the human genome is predominantly 
heterochromatic, these results have had a profound effect on our understanding of the 
definition and functions heterochromatin. Among many other implications, this emerging 
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paradigm challenges the notion that DNA accessibility is the major mode of 
transcriptional regulation in higher eukaryotes.  
 Evidence of pervasive transcription is also in line with the growing appreciation 
that RNA products are no longer exclusively dedicated to gene expression, protein 
synthesis machinery, or RNA processing machinery. In fact, one of the major products of 
transcription are non-coding RNAs (ncRNAs) that have regulatory capabilities, such as 
microRNAs and lncRNAs. Progress within this field has not only contributed to the 
understanding of the diverse roles of ncRNA, but also how they are regulated at the level 
of chromatin. Algorithms have shown that ncRNAs and other transcriptional outputs map 
very closely with unique combinations of chromatin factors, including histone PTMs and 
variants, readers, writers and erasers.104 A major implication extending from these 
bioinformatic studies is that physiological chromatin exists in a myriad of states that 
presumably help to organize and regulate complex transcriptional programs. Several 
studies have already described dozens of chromatin states in a wide range of organisms 
using datasets limited to only small proportion of all the known histone PTMs and their 
associated enzymes. 104-107 Therefore, a more comprehensive view of histone PTM states 
is needed to help resolve the increasing intricacies of chromatin.  
 
1.7   TETRAHYMENA AS A MODEL ORGANISM  
 The ciliated protozoan Tetrahymena thermophila is a very useful model organism 
for chromatin biology. Several seminal discoveries in biology have resulted from studies 
of Tetrahymena, including the initial characterization of telomeres and telomerase, the 
discovery of catalytic RNA, and the function of histone acetylation.35,108-110 These 
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discoveries were facilitated in large part by the unique physiological characteristics of 
Tetrahymena that afforded unprecedented access to the underlying biology.   
 Much like metazoans, Tetrahymena have physically separate somatic and 
germline genomes. 111-113 However, in ciliates these genomes are compartmentalized in 
two physically separable nuclei found within a common cytoplasm (Figure 3A). The 
micronucleus contains the germline genome, which is activated during sexual 
reproduction (conjugation) and functions to produce new somatic and germline genomes 
in the progeny (Figure 3B). The macronucleus (MAC) contains the somatic genome, 
which is the site of gene expression in Tetrahymena during asexual (vegetative) growth 
and conjugation (Figure 3B). The macronuclear genome does not contribute DNA to 
subsequent generations, although there is some evidence that it can have an epigenetic 
role in the formation of the progeny genome.114  
 The macronuclear genome undergoes several programmed DNA rearrangements 
and processing during conjugation that ultimately becomes significantly differentiated 
from the micronuclear genome. The genomes differ in the following ways. Firstly, the 
macronuclear genome lacks about 33% of the DNA sequence information of the 
micronuclear genome. The disparity occurs as a result of active DNA elimination of 
micronuclear-limited sequences (also known as internal eliminates sequences [IESs]).115  
Since these sequences are often intergenic, repetitive, and transposon–like sequences, the 
macronucleus is thought to be ‘streamlined’ for transcription, as it is highly enriched for 
genic and regulatory DNA sequences.112 Another class of sequences targeted for 
elimination is centromeric DNA. Indeed, macronuclear chromosomes lack centromeres 
causing it to divide amitotically (a process akin to diffusion) during vegetative growth, 
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whereas micronuclei retain their centromeres and divide mitotically.116, 117 Secondly, the 
macronuclear genome undergoes massive fragmentation at specific sites (~15 bp) known 
as chromosome breakage sequences (Cbs).111 This fragmentation results in the formation 
of hundreds of chromosomes. By comparison, the micronucleus only contains 5 
chromosomes. Finally, although the macronuclear genome lacks the full complement of 
the Tetrahymena genome, it is highly amplified, containing about 45 copies of each 
chromosome. Therefore, the macronuclear genome contains about 20X the chromatin 
content of the diploid micronuclear genome.  
In addition to their genomic content, macronuclei and micronuclei greatly differ 
in their chromatin states. During vegetative growth, several studies have shown that 
micronuclei are transcriptionally silent.118 In fact, micronuclei are dispensable for the 
viability of Tetrahymena during vegetative growth, strongly suggesting that micronuclei 
are functionally inert during this stage of the life cycle.119 Consistent with these 
observations, several cytological studies using transmission electronic microscopy and 
heavy metal staining have shown that the micronuclear chromatin is relatively dense 
compared to macronuclei and macronuclear chromatin appears to be loosely associated, 
much like euchromatin.120 Notably, macronuclear chromatin is not uniformly 
euchromatic since it also contains a punctate pattern of cytologically dense regions. 
Adding to these differences, macronuclei and micronuclei also differ in the types of 
histone variants present within each compartment. Namely, the linker protein histone H1 
is present in macronuclei, but absent in micronuclei.121 Instead, micronuclei contain four 
high-mobility-group-like proteins called alpha, beta, gamma, and delta.122 Important to 
the findings described in the dissertation, macronuclei and micronuclei also contain 
	   25	  
distinct histone H3 proteins. Macronuclei contain two H3 isoforms termed major and 
minor that correspond to human histone H3.2 and H3.3, respectively. Interestingly, minor 
H3 is absent in micronuclei, and the major H3 exists in two forms: a full-length form that 
is indistinguishable from macronuclear major H3; and a proteolytically processed 
(‘clipped’) form that lacks the first six amino acids of the N-terminal tail of major H3.123 
Because the clipped form is smaller and runs faster in electrophoretic assays, it is 
sometime referred to has H3 fast (H3F) and the full-length formed is called H3 slow 
(H3S). While the function of histone clipping in the transcriptionally silent micronucleus 
is not known, it is important to note that the clipped peptide includes H3K4, which when 
methylated could serve as a strong activator of transcription. 
 Are the structural and functional differences of macronuclei and micronuclei 
recapitulated in their histone PTMs states? Previous studies have shown that 
macronuclear histones contain the PTM hallmarks of active transcription; namely, they 
are highly acetylated and histone H3 contains H3K4me3.57, 124 Antibody based studies 
have also suggested that macronuclei contain the heterochromatic H3K27me3 mark, 
although it is not clear if it colocalizes with the cytologically dense regions described 
above. Notably, it is known that micronuclei lack H3K4me3 and histone acetylation. 
Moreover, H3K27me3 is highly enriched in the micronucleus, in accordance with its 
transcriptionally ‘off’ status.57 Thus, the functional dichotomy of the biochemically 
separable nuclei of Tetrahymena makes it an excellent model organism to study 
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CHAPTER 2: IDENTIFICATION OF HISTONE H3 LYSINE  
   23 METHYLATION IN GERMLINE    
   HETEROCHROMATIN  
 
2.1   INTRODUCTION 
 Recent advances in mass spectrometry and genome-scale analyses have suggested 
the existence of several chromatin states with unique functional, transcriptional, and 
molecular properties. Moreover, results from the ENCODE consortium have shown that 
the majority of the human genome, including constitutively heterochromatic regions, are 
transcribed to some degree. Within this context, the cytological definition of 
heterochromatin is rather simplistic, but a comprehensive molecular definition still 
remains elusive. Of particular importance is the array of histone PTMs that occur within 
these transcriptionally repressive environments. However, biochemical dissection of 
distinct chromatin types is problematic since they are often found on contiguous stretches 
of DNA in most eukaryotic cells. Coupled with the fact that all chromatin states are 
compartmentalized within a single nucleus, obtaining highly enriched samples of distinct 
chromatin types at scales necessary for the detection of their underlying histone PTMs is 
insurmountable at the present time.  
 Take, for example, the inactive X (Xi) chromosome of female mammals.  
It is well established through antibody-based approaches that H3K27me3 is enriched and 
histones are hypoacetylated on Xi, but whether other histone PTMs are contributing to 
silencing is not known.125,126 Therefore, there is great interest in obtaining a 
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comprehensive list of the histone PTM states found with Xi, but no study to date has 
successfully developed a method that enriches for Xi chromatin to the extent required for 
PTM analysis. This is in large part due to the fact that the Xi, although not covalently 
linked to other chromosomes, is physically found intermingled with the other 
chromosomes within the same nucleus. 
 To obtain highly enriched heterochromatin and screen for novel histone PTM 
states, we took advantage of the nuclear dimorphism of Tetrahymena. In addition to the 
functional and physiological differences between macronuclei and micronuclei, previous 
studies have shown that they also contain disparate histone PTM states. In line with its 
transcriptional status, the macronucleus contains hyperacetylated core histones and H3K4 
methylation.57 Furthermore, antibody based and mass spectrometry approaches have 
shown that the macronucleus also contains H3K27 mono-, di-, and trimethylation.57 In 
the cases of H3K27me1 and H3K27me2, these modifications can occur with H3K4me1 
in cis on the same N-terminal peptide, suggesting the presence of bivalent-like 
transcriptional regulation in the macronucleus. The role and genomic localization of 
H3K27me3 in the macronucleus has not been studied to date. However, given that 
approximately half of the ~21,000 genes in Tetrahymena are not transcribed during 
vegetative growth, and the fact that no other heterochromatin associated histone 
methylation (such as H3K9me) is known to occur in the macronucleus, H3K27me3 likely 
mediates gene silencing programs in this compartment. In support of this idea, a homolog 
of HP1, called Hhp1p, in Tetrahymena has been shown to specifically localize to the 
macronucleus, bind to H3K27me3, and mediate starvation induced gene silencing.127   
 Similar mass spectrometry driven attempts to identify histone PTMs in 
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micronuclei have been lacking, in large part due to the difficulty of purifying 
micronuclei. Nevertheless, antibody based studies have helped identify some of the 
PTMs associated within this compartment. Notably, it was discovered that histone H3 
serine 10 is phosphorylated (H3S10ph) in mitotic micronuclei.128 Since its discovery in 
Tetrahymena, H3S10 hyperphosphorylation has been shown to be a universal marker of 
mitosis.45 In contrast to macronuclear core histones, micronuclear core histones are 
hypoacetylated.124,129  Finally, micronuclei are lacking in H3K4 methylation and are 
highly enriched for H3K27 trimethylation.57 Aside from these modifications, no other 
modifications are known to occur on micronuclear H3.  
 Perhaps the most surprising aspect of histone PTMs in micronuclei and 
macronuclei is the fact that neither contains H3K9 methylation during vegetative growth. 
In the context of the macronucleus, the lack of H3K9 methylation is not so problematic 
because the DNA elements that are typically associated with this mark (namely 
repetitive, structural and pericentric DNA) are actively eliminated from the genome 
during conjugation. Interestingly, these eliminated elements are targeted for H3K9 
methylation in new macronuclei during conjugation.115 The lack of H3K9 methylation in 
the micronucleus is more difficult to explain. One implication stemming from this fact is 
that H3K27me3 in the micronucleus may target multiple different classes of genomic 
elements (intergenic vs. genic). However, the parsimonious explanation follows that there 
is at least another histone modification that underlies these eliminated regions within the 
micronucleus.   
 Advances in mass spectrometry have long supported the identification and study 
of histone PTMs. As the chromatin field moves from identifying single histone PTMs to 
	   29	  
characterizing combinatorial interplay or “crosstalk” among histone PTM states, 
specialized techniques like ECD (electron capture dissociation) and ETD (electron 
transfer dissociation) have helped identify novel combinations of modifications in cis on 
relatively long histone peptides (>20 amino acids).130-133 In this study, we employed an 
in-line liquid chromatography-mass spectrometry (LC-MS) strategy wherein a polyCAT 
column (cation exchange) and an organic mobile phase (acetonitrile) are directly coupled 
to an ETD enabled LTQ-FT mass spectrometer and an ion trap mass spectrometer 
(collectively called HILIC-MS/MS). This high-resolution method allows for the 
separation of large histone peptides that differ by charge and as few as one methyl group. 
Despite this capability, HILIC-MS/MS still requires front-end purification of complex 
samples to yield interpretable spectra. Therefore, samples from Tetrahymena are ideal for 
HILIC-MS/MS because they are relatively under modified compared to human histones, 
and upon successful purification of micronuclei would provide highly enriched 
heterochromatin histones.  
 
2.2   METHODS  
2.2A   CELL CULTURE AND STRAINS 
 Wildtype Tetrahymena strains CU427 and CU428 were provided by the 
Tetrahymena Stock Center (http://tetrahymena.vet.cornell.edu/). Standard culture media 
and conditions were used.113 All experiments using vegetative Tetrahymena involved 
cells growing at mid-log phase (~2.5 X 105 cells/mL). Conjugation was induced as 
previously described.113, 134  
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2.2B   PREPARATION OF MICRONUCLEAR HISTONE H3 
 Micronuclei were isolated following suggested conditions from published 
protocols.113, 135 Minor modifications to these protocols yielded purified micronuclei in a 
highly reproducible manner. Unless otherwise stated, centrifugation was done for 5 min 
at each step. Typically, the first fraction (pure macronuclei) was obtained by 
centrifugation at 610g. The next fraction was collected at 780g and it often contained 
pure macronuclei. Fractions 3-8, containing a mixture of MAC/MIC, were collected by 
centrifugation at the following increments: 970g, 1190g, 1430g, 1680g, 1970g, and 
2100g, respectively. By fraction 8, the MAC to MIC ratio was typically 1:10. At this 
point, the g forces of each centrifugation step were increased by increments of 100g until 
macronuclei were completely clarified. This typically occurred at 2600g. If macronuclei 
were still present after centrifugation at 2600g, subsequent fractions were collected at 
2600g using 5 min increments (i.e. 5 min, 10 min, and so on) until macronuclei were 
almost completely clarified. Once the macronuclei were removed, 3-4 fractions were 
collected (using 5 min increments per fraction) at 3500g to obtain highly purified 
micronuclei.  
 In optimizing these conditions, I learned of a few pitfalls that lessen the chances 
of obtaining pure micronuclei. As I have not had a chance to systematically test each of 
these recommendations, they are anecdotal in some respect. Nevertheless, the first and 
perhaps most important recommendation is that it is critical to follow the increments 
described above. Ramping up the centrifugal forces faster than recommended above in an 
effort to expedite the procedure often leads to incomplete removal of macronuclei. The 
next recommendation pertains to the total volume of medium B used during the 
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preparation. I have found that pelleting the nuclei in volumes less than 200 mL of 
medium B (in 250 mL Corning conical tubes) reduces micronuclei purity. Therefore, 
since the concentration of cells in medium B is 1.5 X 106 cells/mL, each experiment 
should minimally include 3 X 108 cells (or ~1.5 L of cells at mid-log phase). Finally, it is 
important to blend for one minute on high in between each step of centrifugation. This 
ensures that the nuclei are not clumped and are homogenously distributed in medium B 
prior to pelleting.  
 Once isolated, nuclei from each fraction were stained with DAPI and the 
MAC/MIC ratio of each fraction was determined by fluorescence microscopy. 
Alternatively, nuclei were stained with methyl green and observed by light microscopy. 
In all experiments, micronuclear fractions containing less than 0.1% macronuclear 
contamination were pooled. Then, total histones were extracted in 0.4 N H2SO4 and the 
histone isoforms were separated by reversed-phase HPLC using a C8 column (220 X 4.6 
mm, Aquapore RP-300, Perkin Elmer) following previously described methods.136  
HPLC fractions were analyzed by SDS-PAGE and Coomassie blue staining. HPLC 
fractions containing micronuclear histone H3 were pooled, dried under vacuum, and their 
PTM states were analyzed by HILIC-MS/MS.  
 
2.2C   HILIC-MS/MS ANALYSIS OF MICRONUCLEAR H3 PTM STATES 
 N-terminal tails of purified micronuclear histone H3 species, H3S(1-50) and 
H3F(7-50), were obtained by GluC digestion and analyzed by hydrophilic liquid 
chromatography coupled with high resolution MS1 and linear ion trap ETD MS/MS 
(HILIC-MS/MS). Dried RP-HPLC fractions containing micronuclear H3 (fractions 56-
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58) were reconstituted in 100 mM ammonium acetate (pH 4.1) and digested with 
endoproteinase Glu-C (Roche Applied Science) at a ratio of 1:20 enzyme to protein for 4 
hours at 37 C.  Digestion was quenched by freezing the samples at -30 C.   
An aliquot of the endoproteinase Glu-C digested H3 histone peptide solution (5 
pmole) was dried to completion in a Savant SpeedVac® and reconstituted in solvent A (as 
described below) prior to pressure loading onto fused silica capillary analytical column 
(360 µm o.d. x 75 µm i.d.) containing 10 cm of PolyCAT ATM  (300 Ǻ pore size, 3 µm 
diameter, Poly LC Inc., Columbia, MD) equipped with an integrated electrosprayemitter 
tip. Peptides were gradient eluted off of the column using a linear gradient as previously 
described.132 The eluent was directly introduced into a front-end electron transfer 
dissociation enabled LTQ-FT (Thermo Scientific) mass spectrometer. MS1 spectra were 
acquired in the high-resolution FT mass analyzer and MS2 spectra were acquired in the 
linear ion trap mass analyzer. Following each high resolution MS1 spectrum, eight data-
dependent low-resolution ETD MS2 spectra were acquired. All MS2 spectra were 
collected using the following instrument parameters: one microscan, 3 m/z isolation 
window, default charge state of +10, monoisotopic precursor selection “enabled”. Full 
automated gain control targets were set to 1e6 for FTMS and 6e5 for ITMS. In addition 
dynamic exclusion was enabled and set for a repeat count of 2, repeat duration of 30 s, 
exclusion list of 150 masses, and exclusion duration of 20 s. Azulene was the electron 
transfer reagent.   
All MS/MS spectra were searched against a Tetrahymena histone H3 protein 
database using the Open Mass Spectrometry Search Algorithm (OMSSA).137 Prior to 
searching the data, MS2 peak lists were generated using a Java-based program written in-
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house (Dr. Donald Hunt, University of Virginia, Charlottesville, VA). All searches were 
completed using either the “no enzyme” or “Glu-C” digestion parameter. Precursor and 
peptide mass tolerances were set to +/- 0.05 and +/- 0.35, respectively. Search parameters 
included the following variable modifications: mono-, di-, and tri-methylation of Lys; 
acetylation of Lys; and phosphorylation of Ser, Thr, Tyr.  OMSSA removed the reduced 
charge species from the ETD peak lists prior to searching the data. Results from the 
searches were used as a guide for data analysis. All data were interpreted manually in 
order to determine sequence coverage and modification sites.   
 
2.2D   PEPTIDE SYNTHESIS AND HISTONE H3 PEPTIDES USED IN THIS STUDY 
 Peptides were synthesized using a Prelude Synthesizer (Protein Technologies) 
using standard Fmoc-based solid phase peptide chemistry. Peptides were cleaved from 
the resin by Reagent K, precipitated in diethyl ether, and purified using Varian Dynamax 
Microsorb C18 preparative column (Agilent, Santa Clara, CA). The masses of HPLC-
purified peptides were confirmed by MALDI-TOF mass spectrometry. Below is a list of 
peptides that we used in the dissertation. Those marked with and asterisk were synthesize 
in-house. The numbers in the parenthesis of each peptide name correspond to the residues 
of the H3 N-terminal tail. Peptides with an asterisk were synthesized in-house.   
 
Peptides: 
Unmod (18-36)-  KQLASK23AARK27SAPATGGIK(biotin)* 
K23me3 (18-36)-  KQLASK23(me3)AARK27SAPATGGIK(biotin)* 
K23me3 (19-28)-  QLASK23(me3)AARK27C* 
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K27me3 (18-36)-  KQLASK23AARK27(me3)SAPATGGIK(biotin)* 
K23/27me3 (18-36)-  KQLASK23(me3)AARK27(me3)SAPATGGIK(biotin)* 
Unmod (1-20)-  ARTK4QTARK9STGGKAPRKQLY (Gift from C.D. Allis) 
K4me3 (1-15)-  ARTK4(me3)QTARK9STGGKAY*  
K9me3 (1-15)-  ARTK4QTARK9(me3)STGGKAY* 
K23me1 (20-28)-  CLATK23(me1)AARK27S (Active Motif) 
K23me2 (20-28)-  CLATK23(me2)AARK27S (Active Motif) 
 
2.2E   GENERATION OF THE H3K23ME3 SPECIFIC POLYCLONAL ANTIBODY  
 α-H3K23me3 antibodies were generated by injecting rabbits (Cocalico 
Biologicals Inc.) with a synthetic peptide spanning amino acids 18-36 of histone H3 and 
containing a trimethylated lysine 23 modification (H3K23me3[18-36]).  
H3K23me3-specific antibodies were affinity purified from rabbit serum as 
previously described.138 Briefly, IgG from the serum were precipitated in 50% 
ammonium sulfate (saturated) and resuspended in 1 X PBS + 1 mM PMSF. The IgG 
were then passed through a gravity column containing SulfoLink beads (Thermo 
Scientific) coupled to the non-native cysteine of a short synthetic peptide, K23me3 (19-
28), from the H3 N-terminus containing the H3K23me3 modification. Bound antibodies 
were eluted with 100 mM glycine pH 2.5 and the eluate was immediately neutralized to 
pH ~7 with 1 M Tris pH 8.0, flash frozen, and stored in -80 °C. 
Specificity of the purified IgG was evaluated by ELISA. Greiner high-binding 96-
well plates (Sigma) were incubated with peptides diluted in 0.05 M carbonate buffer pH 
9.6 overnight, blocked with 1% BSA resuspended in PBS-T (1 X PBS pH 7.4 + 0.05% 
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Tween 20) for 1 h, incubated with affinity purified α-H3K23me3 diluted in PBS-T 
(1:100) for 1.5 h, and incubated with HRP-conjugated α-rabbit secondary antibody (GE 
Life Sciences) diluted in PBS-T (1:5,000) for 1.5 h. All incubation steps were carried out 
at 37 °C followed by 3X washes with PBS-T. To detect the ELISA signal, plates were 
treated with stable peroxide substrate buffer (Thermo Scientific) supplemented with OPD 
(Thermo Scientific) following manufacture’s procedures and the absorbance at 492 nm 
was measured using a microplate reader. Peptides were bound in triplicate in each plate 
and all ELISA experiments were repeated at least three times. Representative results from 
a single experiment are presented and the error bars denote standard deviation of 
triplicate samples. Peptide competition experiments for ELISAs were carried out by 
incubating the indicated peptides at a concentration of 5 µg / mL (of PBS) with the 
antibodies for 1 h on ice prior to their use.  
 
2.2F   WESTERN BLOT AND INDIRECT IMMUNOFLUORESCENCE ANALYSES 
 SDS-PAGE was performed as described 57,139 or materials and procedures 
corresponding to Novex NuPAGE precast gel system were used (Life Technologies). The 
procedures for methanol fixing and indirect immunofluorescence staining of 
Tetrahymena cells are described previously.140  
Rabbit polyclonal antibodies used for Western blotting included: α-H3 
(Tetrahymena H3 #117; 1:5,000; gift from C.D. Allis), α-H3K23me3 (1:100; made in 
this study), α-H3S10p (1:25,000; gift from C.D. Allis), α-H3K9me3 (1:1,000; ab8898; 
Abcam), α-H3K27me3 (1:2,500; 39155; Active Motif), α-H3K23me1 (1:1,000; #39387; 
Active Motif), and α-H3K23me2 (1:1,000; #39653; Active Motif). HRP-conjugated α-
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rabbit secondary antibodies (GE Life Sciences) were used at dilution of 1:5,000 and 
detected by ECL plus reagent (Amersham) following manufacturer’s procedures.  
 For Tetrahymena immunofluorescence staining, cells were fixed in partial 
Schaudin’s fixative as described.140, 141 The primary antibodies used were: rabbit α-
H3K27me3 (1:250; gift from T. Jenuwein), mouse α-H3K4me3 (1:250; ab1012; Abcam), 
rabbit α-H3K23me3 (1:100; made in this study), rabbit α-H2A (1:250; control stain for 
Tetrahymena), mouse α-H3K9me3 (1:100; 39285; Active Motif), rabbit α-H3K23me1 
(1:250; Active Motif), and rabbit α-H3K23me2 (1:250; Active Motif). Secondary 
antibodies, used at a dilution of 1:2000, included Alex Fluor 647-conjugated goat α-
mouse, Alexa Fluor 488-conjugated goat α-rabbit, and Alex Fluor 488-conjugated goat 
α-mouse (Molecular Probes). Slides were mounted in ProLong Gold antifade reagent 
with DAPI (P36931; Life Technologies) and stored overnight at room temperature prior 
to imaging. Digital images were captured using a Zeiss Axio Observer fluorescence 
microscope equipped with an Apotome for optical sectioning and AxioCam MRm 




2.3   RESULTS 
2.3A   PURIFICATION OF HISTONE H3 FROM THE MICRONUCLEUS  
To highlight the different histone PTM signatures found within macronuclei and 
micronuclei, we performed co-immunofluorescence staining of Tetrahymena growing 
under vegetative conditions. As expected, the results show that the heterochromatic 
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micronucleus is relatively enriched for H3K27me3 while it completely lacks H3K4me3 
(Figure 4). The macronucleus is positive for both the H3K27me3 and H3K4me3 marks, 
although by our co-immunofluorescence staining they appear localized to distinct sub-
nuclear domains (Figure 4, merge). Although previous studies have also shown that the 
macronuclear genome is streamlined for gene expression, these results suggest that 
transcription is highly regulated by silencing/activating pathways (and perhaps distinct 
chromatin states) that have not yet been fully interrogated. Comparatively, the 
micronucleus appears to be less complex than the macronucleus in terms of histone PTM 
states and in overall function during vegetative growth.57   
Two major properties of Tetrahymena physiology facilitate the biochemical 
purification of micronuclei. First, the micronucleus is a membrane-bound organelle that 
is separate from the macronucleus.120 This feature allows micronuclei to remain intact in 
vitro after outer membrane lysis. Second, although the micronucleus is cytologicalldenser 
than the macronucleus, its genomic content (2N), and by extension its weight, is at least 
20 times less than the polyploid macronucleus (45N).112 Together, these factors allow for 
the separation of micronuclei from macronuclei using differential centrifugation. 
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However, the decades-old protocol for nuclear preparation from Tetrahymena has been 
optimized and overwhelmingly used for the purification of macronuclei. 113 Purification 
of micronuclei is considerably more problematic because a single macronucleus has 20 
times the contaminating effect than a micronucleus. For example, a fraction containing a 
1:1 ratio of macronuclei to micronuclei actually contains a 20:1 ratio of macronuclear to 
micronuclear chromatin. Therefore, I initially had to optimize the nuclear preparation 
protocol to significantly minimize macronuclear contamination (the protocol is detailed 
in the Methods section of this chapter).  
By optimizing this differential centrifugation approach, I was routinely able to 
obtain nuclear fractions that were >99.9% pure micronuclei (Figure 5A). This ensured 
that macronuclear chromatin content was <2% of the micronuclear samples used during 
subsequent analyses. Once purified, micronuclear histones were acid-extracted and 
resolved by reverse-phase HPLC (Figure 5B). SDS-PAGE separation and Coomassie 
staining of H3-containing HPLC fractions (56-58) showed that I was able to achieve an 
extremely high degree of purification for micronuclear H3, which occurs in two 
electrophoretically distinct forms in vivo (Figure 5C). The electrophoretically slow form 
of micronuclear H3, H3S, is the same sequence as macronuclear H3, and the fast form, 
H3F, is derived from H3S during a micronucleus-specific proteolytic processing step that 
irreversibly removes the first six amino acids from the H3S N-terminus.123  
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2.3B   COMBINATORIAL MODIFICATION STATES OF MIC HISTONE H3 TAILS  
 To determine the histone PTM states associated with micronuclear H3, highly 
purified H3S and H3F from micronuclei of vegetative cells were analyzed using HILIC-
MS/MS. HILIC offered sufficient separation of the large, hydrophilic, highly modified 
H3 peptides. In fact, under these chromatographic conditions, N-terminal tails from H3F 
(amino acids 1-50) and H3S (amino acids 7-50) were separated into distinct fractions 
(data not shown). In addition, ETD provided complete to near complete fragment ion 
coverage allowing for interrogation of modifications that occur on single peptide 
molecules. 
 Our mass spectrometric analysis of micronuclear H3 PTMs is represented in 
schematic form (Figure 6). This analysis revealed that, similar to condensed chromatin in 
higher eukaryotes, H3S and H3F were collectively hypoacetylated.29 The few multiply 
acetylated states on H3S and H3F are devoid of methylation marks in cis and likely 
represent newly deposited histone H3 in micronuclei.142 H3K4me1, which is commonly 
associated with euchromatin and histone deposition143, was also detected on micronuclear 
H3S, but was absent on H3F, as H3K4 is missing on this proteolytically processed form. 
As expected from our previous studies, H3K9 methylation was not detected on any 
isoforms of micronuclear H3, while H3K27me3 and the mitosis associated PTM 
H3S10ph were only detected on H3F.57, 115, 128, 144 Surprisingly, we detected methylation 
on H3K23, which was specific to H3F and mostly occurred in combination with 
H3K27me. To validate the presence of H3K23 methylation within Tetrahymena, we 
obtained existing antibodies reported to recognize H3K23me1 and H3K23me2, and 
showed that these PTMs are detectable on micronuclear H3 (Figure 7A-B). We also 
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detected H3K23me1 in macronuclei, but this signal is likely non-specific given that α-
H3K23me1 binds to acetylated histones to an appreciable degree.55   
Although a few studies have identified H3K23 methylation through Edman 
degradation, mass spectrometry, and available commercial antibodies (α-H3K23me1 and 
α-H3K23me2 only), a biological understanding of this modification has been lacking.55, 
145, 146 There is in vitro evidence showing that HP1 can bind to H3K23 methylated 
peptides, thereby linking this mark to heterochromatin.55 Curiously, levels of H3K23 
mono, di, and tri-methylation are exceedingly low, and in most cases H3K23me3 is 
undetectable in the somatic cell lines studied to date.55, 74, 145 In this work, we focused on 
characterizing H3K23me3 since this PTM was highly associated with H3K27me3, and 
the H3K23me3/H3K27me3 PTM state was most abundant out of all the dually 
methylated H3K23/H3K27 states (Figure 6, red asterisks). To investigate the function 
of this under-characterized histone PTM, we first had to develop an antibody specific for 
H3K23me3 as none were commercially available at that time. 
 
2.3C   GENERATION OF A POLYCLONAL ANTIBODY SPECIFIC FOR H3K23ME3 
 Antibodies against H3K23me3 were generated using a synthetic H3 peptide 
containing residues 18-36 of the H3 tail and the H3K23me3 modification (Figure 8A, 
underlined in red). Our initial ELISA analysis revealed that the serum was unable to 
distinguish between unmodified H3 (18-36) peptide and H3K23me3 (18-36) modified 
peptide (data not shown). As detailed in the Methods section above, we obtained 
H3K23me3 specific antibodies using affinity purification and a smaller bait peptide 
(H3K23me3[19-27]). ELISA analysis of the affinity-purified antibody was then carried 
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out to test for specificity. As shown in Figure 8B, the antibody was highly specific for 
peptides containing the H3K23me3 mark. Furthermore, preincubation of the antibody 
with excess H3K23me3 peptide, but not H3K4me3, H3K9me3, or H3K27me3 peptides, 
competed away immunoreactivity for H3K23me3 (Figure 8C). The antibody was also 
tested against distinctly methylated forms of H3K23 and only the H3K23me2 peptide 
was weakly recognized (Figure 8D). Notably, the antibody did not bind to the H3K9me3 
peptide, even though the neighboring sequence of H3K9 is very similar to that of H3K23 
(Figure 8A, yellow boxes). Thus, the antibody is highly specific for H3K23me3, and 
importantly, the presence of H3K27me3 did not occlude it from binding to the dual 
H3K23me3/H3K27me3 PTM state we identified in Tetrahymena. This antibody, referred 
to as “α-H3K23me3” hereafter, was used in all of the subsequent studies described 
below. 
 
2.3D   H3K23ME3 IS A GERMLINE SPECIFIC HISTONE PTM 
 To confirm the utility of α -H3K23me3 as a probe for following H3K23me3 in 
Tetrahymena, we tested the antibody in Western blots using acid extracted histones from 
highly purified micronuclei and macronuclei. In line with our HILIC-MS\MS analysis, 
the α -H3K23me3 antibody specifically recognized H3F of micronuclear histone H3 
(Figure 9A). The antibody also failed to recognize recombinant H3 indicating that 
H3K23me3 is required for effective epitope recognition. Finally, we tested the efficacy of 
this antibody in immunofluorescence assays. α -H3K23me3 specifically stained the 
micronucleus and was completely excluded from the macronucleus and the cytosol 
(Figure 9B). Our results confirm that H3K23me3 is present in vivo, and exclusively  
	   47	  
 
	   48	  
 
 
	   49	  
localized to H3F isoform in micronuclei of Tetrahymena. Furthermore, calf intestinal 
phosphatase treatment of micronuclear H3 did not increase the levels of H3K23me3, 
suggesting that neither H3S10 phosphorylation nor other unknown phosphorylation 
events on micronuclear H3 do not occlude the antibody form binding to H3K23me3 
during vegetative growth (Figure 10). Coupled with the fact that we did not detect 
H3K23me3 in our previous ETD analysis of macronuclear H3, these observations suggest 
H3K23me3 is exclusive to the Tetrahymena germline. 
 
2.3E   H3K23ME3 IS SIGNIFICANTLY UPREGULATED DURING MEIOSIS 
 The aforementioned biological experiments were carried out using Tetrahymena 
maintained in an asexual (or vegetative) growth cycle. Since we found that H3K23me3 
was restricted to the germline micronucleus during vegetative growth, we wanted to 
explore the possibility that H3K23me3 would play an important role during conjugation, 
when micronuclear function is most evident. The developmental stages of conjugation 
include pairing of opposite mating types, meiotic division of micronuclei, fertilization, 
mitotic division of zygotic nuclei, and micronuclear differentiation (to form new somatic 
macronuclei) while the parental macronuclei degrade (Figure 11).111 Importantly, 
conjugation proceeds in a synchronous manner, allowing the study of histone PTMs at 
specific developmental windows. 
 Whole-cell-extracts were collected at specific time points during conjugation, and 
probed with α -H3K23me3 as well as other antibodies routinely used to gauge the 
progression of conjugation. Western blot analysis revealed that, compared to H3K23me3 
levels detected in vegetative or starved cell extracts, H3K23me3 levels greatly increased 
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early in conjugation, peaking around hour 4, and diminishing to pre-conjugation levels by 
hour 8 (Figure 12A). Interestingly, the increase in H3K23me3 signal occurred before 
H3S10 phosphorylation (Figure 12B), which is a conserved histone PTM marker for 
mitotic division. This pattern suggests that H3K23me3 is increased during meiosis, the 
developmental stage that precedes micronuclear mitosis. 
The dynamic regulation of H3K23me3 levels early in conjugation, as revealed by 
Western blot analysis of whole-cell-extracts, suggested that this mark is involved in early 
stages of meiotic division. Thus, we performed immunofluorescence assays on whole 
cells to characterize the sub-cellular localization of H3K23me3 during conjugation 
(Figure 13). We observed that H3K23me3 was exclusively localized to micronuclei 
throughout conjugation. While increased H3K23me3 coincided with meiotic entry, the 
PTM was still present, although much reduced, during stages of mitosis as evidenced by 
our Western blot, immunofluorescence, and HILIC-MS/MS data (Figures 12B, 13, and 
14). A small amount of H3K23me3 was detected on H3S during conjugation (Figure 
12A), but its absence in macronuclei (as determined by immunofluorescence) suggests 
H3SK23me3 is likely micronuclear in origin and at levels below the detection limit of 
HILIC-MS/MS (Figures 13 and 14). Taken together, our findings suggest that 
H3K23me3 may play an important role during meiotic division, as its levels are 
specifically elevated during this critical developmental stage.    
 The physical linkage between H3K23me3 and H3K27me3 in vegetative and post-
meiotic chromatin prompted us to examine the dynamic changes to H3FK27me3 during 
meiosis. While macronuclear H3SK27me3 levels remain constant throughout 
conjugation, we found that H3FK27me3 levels in the micronucleus increased, peaked 
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(Figure 12B, asterisks) and concurrently diminished with H3K23me3 levels. In contrast 
to the coordinate increase of H3K23me3 and H3K27me3 observed during meiosis, 
H3K9me3, which specifically emerges during nuclear differentiation, was only detected 
after levels of H3K23me3 diminished (Figure 12B). The fact that low levels of 
H3K23me3 detected during nuclear differentiation are present in micronuclei, and not the 
H3K9me3-enriched developing macronuclei (Figure 15), further defines distinct 
functions within heterochromatin for these PTMs.  
 
2.4   DISCUSSION 
2.4A   GERMLINE SPECIFIC FUNCTIONS OF H3K23ME3  
 We used ETD (electron transfer dissociation) mass spectrometry to screen for 
combinatorial histone PTMs of micronuclear H3. We identified H3K23 methylation as a 
micronuclear specific PTM on H3F and used an antibody against H3K23me3 to 
demonstrate that this mark becomes highly enriched during early stages of meiosis. 
Furthermore, we showed that H3K23me3 is completely lacking in the somatic 
macronucleus throughout all stages of Tetrahymena development, providing strong 
evidence that H3K23me3 is a germline specific histone PTM in Tetrahymena. The 
increase of H3K23me3 in meiosis is noteworthy since little is known about the role of 
histone PTMs in governing the structure and function of meiotic germline chromatin. 
With the exception of γH2A.X (detailed in Chapter 4), no other histone PTM has been 
shown to be dramatically upregulated during meiosis, to the best of our knowledge. 
Previous studies have shown, through mass spectrometry, that H3K23 methylation levels 
are exceedingly rare in somatic cells and in particular, H3K23me3 and H3K23me2 levels 
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were not detected in most cases. Our observations in Tetrahymena suggest that 
H3K23me3 may have an evolutionary conserved role in germline heterochromatin and 
therefore may be enriched in germ cells.  
 Supporting a functional and specific role of H3K23me3 in germline chromatin, 
we noticed that this mark appeared to be actively demethylated from the two pronuclei 
that are destined to differentiate into new macronuclei at around hour 6 of conjugation 
(data not available). The loss of H3K23me3 in these nuclei preceded the emergence of 
H3K9 methylation. It is tempting to speculate that the dual H3K23me3/H3K27me3 
signature is characteristic of germline chromatin in Tetrahymena, and that loss of 
H3K23me3 in micronuclei helps to trigger their differentiation into new macronuclei. 
Another implication from these observations is that H3K23me3 could help protect the 
underlying micronuclear genome from DNA damaging programs associated with DNA 
elimination in new macronuclei.   
 In addition to the dramatic upregulation of H3K23me3 during meiosis, this mark 
is present in micronuclear chromatin during vegetative growth, when micronuclei divide 
mitotically. Indeed, our ETD analysis showed that H3K23me3 and H3S10ph can occur 
on the same peptide indicating that H3K23me3 is also present in mitotic chromosomes. 
This suggests that H3K23me3 can be epigenetically inherited through mitotic divisions. 
What is the function of H3K23me3 in vegetative cells? Our immunofluorescence and 
mass spectrometric data indicated that H3K23me3 only marks a subset of micronuclear 
chromatin, indicating that it localizes to specific regions (i.e. telomeric, satellite, 
intergenic, etc.) of the micronuclear genome. Once the cells enter meiosis, the 
H3K23me3 associated chromatin could act as nucleation sites for the spreading and 
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propagation of H3K23me3, which contributes to the regulation of the underlying DNA 
elements. The levels of H3K23me3 in the new micronuclei are returned to baseline 
during late conjugation and again propagated through mitotic divisions in the progeny as 
detected by immunofluorescence (data not shown). Thus, H3K23me3 in vegetative cells 
may help to poise the underlying DNA for downstream processing associated with 
germline development during conjugation. 
 
2.4B   HISTONE PTM CROSSTALK HIGHLIGHTS THE MANY FACETS OF H3K27ME3 
Our observations suggest that H3K27me3 in Tetrahymena occurs in many distinct 
combinations of PTMs during vegetative growth and conjugation that may function to 
silence, index, or otherwise poise the underlying DNA elements for specific biological 
processes. In the micronucleus, H3K27me3 is present on H3 simultaneously with other 
well-known PTMs associated with repression and chromatin condensation. This 
heterochromatic ‘signature’ includes methylation on H3K23, hypoacetylation, and 
proteolytic clipping of H3. However, despite the co-occurrence of H3K27me3 and 
H3K23me3 on a significant subset of micronuclear H3 peptides, the deposition of 
H3K27me3 does not always overlap with that of H3K23me3. While H3K27me3 is only 
found on H3F in the micronucleus, it can also occur on H3S in the macronucleus. 
Furthermore, during conjugation, H3K27me3 coordinates with H3K9me3 in new 
macronuclei to target intergenic sequences for heterochromatin formation and eventual 
elimination. Thus, the co-occurrence of clipping, H3K23me3, or H3K9me3 may underlie 
the many putative functions of H3K27me3 in Tetrahymena.  
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Several lines of evidence support the above hypothesis. Firstly, the Tetrahymena 
chromodomain containing protein Hhp1p121, shown to bind H3K27me3, localizes to 
macronucleus but not the micronucleus. Thus, either Hhp1p is not imported into 
micronuclei or the occurrence of H3K23me3/clipping in cis with H3K27me3 affects its 
binding in micronuclear chromatin. Supporting the latter, we found that the presence of 
H3K23me3 in cis severely lowers the ability of Hhp1p to bind to H3K27me3 peptides 
(Figure 16). Secondly, another Tetrahymena chromodomain protein, Pdd1p, that binds to 
H3K27me3 upstream of heterochromatin formation and DNA elimination is affected by 
the presence of H3K23me3 in cis (Figure 16). Thus, at least two known H3K27me3 
readers are negatively affected by the presence of H3K23me3. By comparison, the as yet 
identified H3K23me3 reader would likely have to bind to the binary 
H3K23me3\H3K27me3 mark since they are predominantly found to occur 
simultaneously in Tetrahymena during vegetative growth and early conjugation.  
 
2.4C   MACRONUCLEI LIKELY CONTAIN TRANSCRIPTIONALLY OPPOSING SUBDOMAINS 
As detailed in Chapter 1 of this dissertation, the macronucleus is the site of gene 
expression during vegetative growth. Still, not all of its ~21,000 genes are expressed 
during this life cycle and, of the expressed genes, most are either up- or down-regulated 
depending environmental or life cycle changes (e.g. cell density, nutrients in media, and 
induction of conjugation). A previous study identified at least 1,158 genes that were 
specifically silenced during vegetative growth and another 2,369 genes that were 
significantly up-regulated during starvation and conjugation.147 Our observation that  
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H3K27me3 and H3K4me3 occupy distinct sub-nuclear domains within the 
macronucleus  suggests that transcription may be regulated, in part, by the localization of 
genes to transcriptionally repressive and permissive environments, respectively. 
Nevertheless, our previous study characterizing histone PTM states of macronuclear H3 
showed an enrichment of H3K4me3 and acetylation, as well as H3K27me1 and 
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CHAPTER 3: LOSS OF HISTONE H3 LYSINE 23    
   METHYLATION LEADS TO DEVELOPMENTAL  
   DEFECTS IN TETRAHYMENA  
 
3.1   INTRODUCTION 
3.1A   THE ENHANCER OF ZESTE FAMILY OF HISTONE METHYLTRANSFERASES  
 SET domain-containing proteins are enzymes that can be involved in the positive 
or negative regulation of gene expression. Named for their occurrence in Suppressor of 
variegation 3-9, Enhance of zeste (E[z]) and Trithorax genes in Drosophila, SET 
domains are proposed to have methyltransferase activity towards lysine residues on 
histones and other targets.148 E(z) is a highly conserved member of the Polycomb group 
proteins important for regulating homeotic genes during Drosophila development.76  
Biochemical studies have shown that E(z) is a member of the polycomb repressive 
complex 2 (PRC2) that writes H3K27me3, which is then read by the chromodomain 
containing Polycomb (Pc) protein of PRC1.76 Similar repressive complexes have been 
described in mammals, invertebrates, plants and Tetrahymena.76, 149, 150  
 
3.1B   E(Z) FAMILY OF METHYLTRANSFERASES ARE GUIDED BY RNA  
 A important commonality among the E(z) family of methyltransferases is that 
their heterochromatin forming activity is thought to be guided by non-coding RNAs 
(ncRNA) in vivo. In higher eukaryotes, several studies have shown that PRC2 binds to 
different classes of ncRNA, including long ncRNA (e.g. HOTAIR) and small ncRNA 
	   63	  
(<150bp). A recent study also showed that Ezh2 (the mammalian homolog of E[z]) can 
promiscuously bind to RNA in a sequence independent manner to regulate the genomic 
localization of PRC2.84 Of note, most studies focusing on E(z) homologs and ncRNAs 
have been conducted in somatic cells.  
 Recent work by our group has shed light on the connectivity of E(z) homologs 
and ncRNAs in the germline of Tetrahymena.150 Specifically, our study showed that 
Ezl1p, which catalyzes H3K27/H3K9 trimethylation of IESs in developing macronuclei, 
is controlled by the upstream activities of piRNA-like small RNA (called scanRNA) 
during conjugation. Very early in conjugation (during leptotene/zygotene of meiotic 
prophase), certain sections of micronuclear genome are transcribed by RNA polymerase 
II. Although the mechanism of RNA polymerase II targeting is not known, these 
transcripts are enriched for micronuclear-limited sequences, which include intergenic, 
repetitive, centromeric, and transposon-like sequences.151 Next, the transcripts are 
processed into scanRNA (28-32 bp) by a dicer-like protein, called Dcl1p. The scanRNAs 
are then bound by an argonaute homolog, Twi1p, in the micronucleus. These scanRNA-
Twi1p complexes then get shuttled to the parental macronucleus (at hour ~5 of 
conjugation) where they presumably ‘scan’ the genome for complementarity. It is thought 
that this process removes the complexes bearing complementary scanRNAs to the 
parental macronuclear genome. The remaining complexes are then shuttled into the new 
developing macronucleus (at hour ~9 of conjugation) where they target the Ezl1p-
catalyzed trimethylation of H3K27 and H3K9 on chromatin bearing IESs. Finally, the 
conjugation specific chromodomain proteins, Pdd1p and Pdd3p, bind to methylated 
histone H3 to form heterochromatin, and to recruit DNA eliminating enzymes. This 
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process takes about 16 h to complete. Studies have shown that disrupting the generation 
of scanRNA in micronuclei during early conjugation leads to aberrations in 
heterochromatin formation in developing macronuclei during late conjugation.150, 152, 153   
 
3.1C   DYNAMICS OF MEIOTIC CHROMATIN  
 Our observations in Chapter 2 indicated that the upregulation of H3K23me3 
occurs at time points consistent with the leptotene, zygotene, and pachytene stages of 
meiotic prophase. These early stages mark critical periods of germline development and 
structural changes to chromatin that contribute to gametogenesis, genetic diversity, and 
genomic stability in all eukaryotes. During leptotene, the chromosomes begin to 
condense and form thread-like structures. Additionally, sister chromatids, which are 
tightly bound, begin to form the synaptonemal complexes necessary for homolog pairing 
and proper segregation. By zygotene, the chromatids are completely paired and 
programmed DNA double strand breaks begin to occur. These sites are marked by 
γH2A.X. Pachytene stage includes the recombination and repair of DNA double-strand 
breaks (DSBs). Additionally, the homologs are fully paired and synapsed by pachytene 
stage, which marks the peak of γH2A.X and the formation of DSBs. Notably, although 
several hundreds to thousands of DSBs are catalyzed during meiotic prophase, only a few 
break sites per cell actually end up recombining.154 As a requisite process of meiotic 
division, DSBs are precisely controlled by cellular checkpoints, and dysregulation of 
these pathways can have deleterious consequences such as genomic instability and loss of 
progeny viability.154-156  
 Chromatin structure is a key factor in controlling programmed DSBs catalyzed by 
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the opportunistic, sequence-independent, and highly conserved endonuclease Spo11 
during early meiotic prophase. The relatively open structural configuration of 
euchromatic regions is thought to make them more susceptible to Spo11 activity. Indeed, 
several recent reports have described a transcription-independent role for H3K4me3 in 
promoting DNA recombination “hot spots”.155   
 Although these recent reports suggest that Spo11 activity is primarily guided by 
euchromatic marks, several reports have shown that proper heterochromatin formation is 
also a critical factor in regulating Spo11 activity. For example, loss of H3K9me3 at 
pericentric heterochromatin in Suv39h dn mice leads to genomic instability in both germ 
and somatic cells.47 DSBs at pericentric heterochromatin are difficult to properly resolve 
because their repetitive nature complicates the repair mechanisms that utilize homologous 
recombination. Therefore, repair of DSBs at these sites are more prone to errors, which 
give rise to phenotypes associated with genomic instability. In the germline, these errors 
can manifest as phenotypes associated with progeny viability and sterility. In that regard, 
Tetrahymena is an interesting organism to study meiotic DSBs since meiotic micronuclei 
lack H3K4me3 and H3K9me3, and H3K23me3 is simultaneously upregulated with the 
occurrence of γH2A.X. 
 
3.2   METHODS 
3.2A   CELL CULTURE AND STRAINS 
 Tetrahymena strains were maintained and conjugation was induced as described 
above (Chapter 2, Methods). ΔEZL2 and ΔEZL3 cells were generated following the same 
procedures used to obtain ΔEZL1 cells as previously described.150   
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3.2B   WESTERN BLOT AND INDIRECT IMMUNOFLUORESCENCE ANALYSES  
 Immune-based assays were performed as described above (Chapter 2 Methods). 
Rabbit polyclonal antibodies used in Western blots in the chapter include: α-H3 (1:5,000; 
gift from C.D. Allis), α-H3K23me3 (1:100; made in this study), α-H3S10p (1:25,000; 
gift from C.D. Allis), α-H3K27me3 (1:2,500; #39155; Active Motif), α-alpha linker 
(1:5,000; gift from C.D. Allis), α-H4 penta acetyl (1:5,000; gift from C.D. Allis), α-
Pdd1p (1:5,000; ab5338; Abcam), α-H3K27me1 (1:1,000; #07-448; Millipore), α-
H3K27me2 (1:500; #07-452; Millipore), α-H3K23me1 (1:1,000; 39387; Active Motif), 
and α-H3K23me2 (1:1,000; 39653; Active Motif). HRP-conjugated α-rabbit secondary 
antibodies (GE Life Sciences) were used at dilution of 1:5,000 and detected by ECL plus 
reagent (Amersham) following manufacturer’s procedures.  
 Tetrahymena immunofluorescence staining was performed in cells fixed in partial 
Schaudin’s fixative as previously described.140, 141 The primary antibodies used were: 
rabbit α-H3K27me3 (1:250; gift from T. Jenuwein), mouse α-H3K4me3 (1:250; ab1012; 
Abcam), rabbit α-H3K23me3 (1:100), rabbit α-H2A (1:250; control stain for 
Tetrahymena), mouse α-H3K9me3 (1:100; #39285; Active Motif), mouse α-γH2AX 
(1:250; #613402; BioLegend), rabbit α-Cna1p (1:5000; Gift of Harmit Malik, Fred 
Hutchinson Cancer Center, Seattle WA), rabbit α-H3K23me1 (1:250; Active Motif), and 
rabbit α-H3K23me2 (1:250; Active Motif). Secondary antibodies, used at a dilution of 
1:2000, included Alex Fluor 647-conjugated goat α-mouse, Alexa Fluor 488-conjugated 
goat α-rabbit, and Alex Fluor 488-conjugated goat α-mouse (Molecular Probes). Slides 
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were mounted in ProLong Gold antifade reagent with DAPI (P36931; Life Technologies) 
and stored overnight at room temperature prior to imaging. Digital images were captured 
using a Zeiss Axio Observer fluorescence microscope equipped with an Apotome for 
optical sectioning and AxioCam MRm camera. Raw images were exported as tiff files 
and processed using Adobe Photoshop software CS3.  
 
3.2C   OBSERVATION OF SMALL RNAS IN TETRAHYMENA  
 Total RNA was extracted with Trizol reagent (Life Technologies) according to 
manufacturer’s procedures and precipitated in ethanol. RNA pellet was dissolved in water 
and the OD260nm was measured. Total RNA (15 µg) from conjugating cells were diluted 
in 2X loading buffer (95% formamide, 18 mM EDTA, 0.025% SDS, and Bromophenol 
Blue) and resolved in a denaturing acrylamide gel (1X TBE, 7 M Urea, 15% acrylamide) 
according to previously described methods150  (see also “Gel purification of miRNA from 
total RNA” protocol from Life Technologies). Gels were visualized by soaking in 1.5 µg 
ethidium bromide per mL of TAE buffer. 152   
 
3.2D   PCR  
 To check the expression status of EZL3 in EZL knockouts, cells were grown to 
mid-log phase, their total RNA was extracted with Trizol reagent (Life Technologies) and 
precipitated in ethanol. Samples were resuspended in water and treated with TURBO 
DNase (Life Technologies) following the manufacturer’s procedures. Reverse strand 
synthesis was carried out using poly dT primers, procedures and reagents from the 
Superscript II RT kit (Life Technologies). EZL3 specific primers (Forward - 
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AATGGTCTATGCTAAAGGTGG; Reverse - TTTGAGAGTTCCTTGTCCATC) were 
used to assess transcript levels and primers that target the ribosomal protein RPL21 
(Forward – AAGTTGGTTATCAACTGTTGCGTT and Reverse - 
GGGTCTTTCAAGGACGACGTA; sequence obtained from Aronica et al. 153 ) 
were used as controls in end-point PCR assays.  
 Quantitative PCR was employed to assess the levels of EZL3 expression during 
conjugation. Total RNA of conjugating cells were harvested at the indicated time points 
during conjugation and processed following procedures described above. qPCR was 
performed using an Applied Biosystems StepOne Plus Real-Time PCR System (Applied 
Biosystems, 4376600) with StepOne Software v2.1 and Power SYBR Green (Applied 
Biosystems, 4367659) to quantify relative mRNA abundance. EZL3 specific primers used 
are shown above. mRNA levels were normalized to time point zero. Samples were 
analyzed in duplicate. 
 
3.2E   PROGENY VIABILITY ASSAY 
For mating survival and progeny production tests, the EZL3 gene deletion was 
reproduced as a somatic knockout157 in the genetic background of strains CU428 and 
B2086. Three independent lines in each background were established by cloning single 
cells from drug-resistant transformants. Each line was starved, mated to each of the 
others and 44 single mating pairs isolated into separate drops of standard growth 
medium.158 After three days growth, surviving cultures were replicated to medium 
containing 6-methyl purine. The 6MP-resistance allele is found in the silent germ line 
nucleus of CU428, but not its somatic nucleus; therefore, resistance indicates the 
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production of true genetic progeny. Survival and progeny production were scored and 
compared with parallel matings of the parental strains. 
 
3.3   RESULTS 
3.3A   AN E(Z) HOMOLOG IS REQUIRED FOR H3K23 METHYLATION IN TETRAHYMENA 
 We sought to identify the methyltransferase responsible for H3K23 methylation to 
obtain better insight into the biological role of this modification in Tetrahymena. Using a-
H3K23me3, we screened for the presence of H3K23me3 in cell lines deleted for various 
HMTs. Initially, we focused the highly conserved E(z) family of SET-domain containing 
proteins that catalyze the di- and tri-methylation of H3K27. We reasoned that disrupting 
H3K27me3 in Tetrahymena may influence H3K23me3 levels, since they co-occur on H3 
tails.  
 Tetrahymena possess three E(z) homologs: Ezl1p (for Enhancer of zeste-like), 
Ezl2p, and Ezl3p (Figure 17A). Previous studies have shown that Ezl1p and Ezl2p are 
required for H3K27 trimethylation during late and early conjugation, respectively.150, 159  
Moreover, Ezl2p is required for both H3FK27me3 in the micronucleus and H3SK27me3 
in the macronucleus during vegetative growth. Ezl1p is not expressed during vegetative 
growth. While Ezl3p is expressed during vegetative growth and conjugation, its histone 
or non-histone targets are not known (Figure 17B). 
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 EZL knockouts (ΔEZL1, ΔEZL2, or ΔEZL3) growing vegetatively were screened 
for changes in H3K23me3 using α-H3K23me3 in Western blot and immunofluorescence 
assays. While H3K23me3 was present at wildtype levels in ΔEZL1 cells, its levels were 
significantly reduced in ΔEZL2 (lacking H3K27me3), and completely undetectable in  
ΔEZL3 cells (Figure 18A-B). These results suggest that expression of Ezl3p is required 
for H3K23me3 (as well as H3K23me1/2) (Figure 19A-B). Supporting a role for Ezl3p in 
meiosis and H3K23 methylation, its expression was strongly upregulated during early 
conjugation (Figure 20). Interestingly, H3K27me3 was moderately reduced on H3F in 
ΔEZL3 cells (Figure 18A, asterisk), while H3K27me1/me2 remained at or slightly 
above wildtype levels (Figure 21), suggesting a functional link between the trimethylated 
forms of H3K27 and H3K23. Since H3K23me3 was most dramatically impacted in 
ΔEZL3 cells, we proceeded to analyze ΔEZL3 cells for phenotypes to better understand 
biological roles of H3K23me3 in vivo. 
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3.3B   DEVELOPMENTAL LAGS IN TETRAHYMENA LACKING H3K23ME3 
 The vegetative growth rate of cells missing Ezl3p and H3K23me3 were about 
20% slower than wildtype (Figure 22). However, since H3K23me3 was particularly 
enriched during early meiosis, we induced conjugation in opposite mating pairs of ΔEZL3 
cells and analyzed them for phenotypes. Whole-cell-extracts of conjugating wildtype or 
ΔEZL3 cells were collected at indicated time points and analyzed by Western blot. 
H3S10ph (mitotic marker) and Pdd1p levels were used as proxies for progression of early 
and late conjugation, respectively (Figure 23A). A significant lag was detected in ΔEZL3 
during early conjugation, exemplified by the delayed onset of H3S10 phosphorylation. 
Moreover, the lag time was amplified at later time points of conjugation, during nuclear 
differentiation, highlighted by the α-Pdd1p immunoblot. Cytologic comparison of 
wildtype and ΔEZL3 mating pairs showed that the initial lag during conjugation began at 
the leptotene/zygotene stages of meiotic prophase (compiled in Figure 23B). ΔEZL3 
cells also showed delayed formation of piRNA-like scanRNA (Figure 23C), a class of 
non-coding RNAs intricately involved with heterochromatin formation and DNA 
elimination at the nuclear differentiation stage of conjugation. Despite a pronounced lag 
in the completion of meiosis, nuclear differentiation, and scanRNA formation, ΔEZL3 
cells apparently recover and proceed to terminal stages of conjugation (Figure 23B, 48h).  
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3.3C   LOSS OF EZL3P AND H3K23ME3 LEADS ECTOPIC DNA DOUBLE-STRAND BREAKS 
 Given the significant early meiotic lag (~1.5 h) observed in conjugating ΔEZL3 
Tetrahymena strains, we next asked whether meiotic DNA damage or repair pathways 
were affected in these mutants. It has previously been reported that in the early stages of 
meiosis, micronuclear chromosomes in Tetrahymena become highly organized - 
centromeres and telomeres segregate to opposite poles of the elongating micronuclei, 
while genic (DAPI-rich) and intergenic (DAPI-poor) regions are suggested to be more 
centrally localized.160, 161 (Figure 24A). Therefore, we used α-γH2A.X to investigate the 
spatial dynamics of DSBs in meiotic ΔEZL3 Tetrahymena cells (Figure 24B).  
DSBs in wildtype micronuclei initiated early in meiosis (leptotene/zygotene) 
within the DAPI-rich genic region, becoming distributed throughout the micronucleus by 
pachytene (Figures 25A). In striking contrast, DSBs in meiotic ΔEZL3 cells initiated in 
the DAPI-poor, centromeric pole of micronuclei and remained localized to that half of the 
micronucleus for the majority of the lag, although γH2A.X localization resembled 
wildtype distribution when cells entered pachytene (Figure 25A). Similar positioning of 
centromeric H3 (α-Cna1p) in both wildtype and ΔEZL3 cells showed that DSBs in 
ΔEZL3 cells directly flanked centromeres, rather than the shift of DNA damage being a 
result of massive genome reorganization (Figure 25B).116 Interestingly, DSBs were not 
mislocalized during leptotene/zygotene in ΔEZL2 cells (lacking H3K27me3) (Figure 26), 
suggesting that only the ΔEZL3 cell line completely lacking H3K23me3 has mislocalized 
meiotic DNA damage.  
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3.3D   LOSS OF EZL3P AND H3K23ME3 LEADS TO REDUCED PROGENY VIABILITY 
 Misregulation of DSB pathways within the germline reduces genomic stability, 
the production of viable gametes, and progeny viability.162 Therefore, we tested whether 
loss of H3K23me3 and ectopic DSB formation translated to reduced progeny viability. 
Although we previously showed that ΔEZL3 cells reach terminal cytological stages of 
conjugation (Figure 23B, 48h), the progeny viability was substantially impaired (Figures 
27A-C). Furthermore, fertility was negatively affected when surviving ΔEZL3 progeny 
were backcrossed to wildtype cells (data not shown). The decrease in progeny viability 
for the ΔEZL3 cells missing H3K23me3 is similar in scope to the reported infertility and 
increased spermatocyte apoptosis in male mice lacking both copies of the H3K9me3 
methyltransferases, Suv39h1/2.63   
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3.4 DISSCUSION  
3.4A   A MODEL FOR THE ROLE H3K23ME3 IN MEIOTIC HETEROCHROMATIN 
Our findings suggest that H3K23me3 is a heterochromatic mark that localizes to 
centromere-proximal and DNA poor regions of the micronuclear genome. The striking 
absence of H3K23me3 in macronuclei may be related to the loss of centromeres and 
intergenic/micronuclear-limited sequences in macronuclear genome that occurs during 
conjugation. We showed that levels of H3K23me3 are dramatically upregulated in 
micronuclei during meiotic prophase, at a developmental stage concurrent with the 
increase of DSB formation and γH2A.X levels. As noted above, meiotic micronuclei lack 
the H3K4me3 and H3K9me3 marks known to regulate meiotic recombination/DSB 
pathways in higher eukaryotes. Our findings that H3K23me3 is upregulated during early 
conjugation and is required for proper DSB localization suggest the existence of novel 
pathway, dominated by H3K23me3, that contributes to the regulation of meiotic DSB 
formation. We propose that H3K23me3 mediates the formation of a higher-ordered 
chromatin structure to protect pericentric heterochromatin from programmed DSB 
formation in Tetrahymena (Figure 28). Supporting this conclusion, the loss of 
H3K27me3, which occurs in cis with H3K23me3 and is the only other heterochromatin-
associated mark in micronuclei, did not lead to ectopic DSB damage (Figure 26).   
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3.4B   THE GENIC TO PERICENTRIC SHIFT IN DSBS OF EZL3P MUTANTS 
 Our data and model highlight a peculiar shift in the formation of DSBs from gene-
rich regions to pericentric DNA in leptotene/zygotene cells lacking H3K23me3. We 
submit that this shift is not a consequence of a change in the substrate specificity of 
Spo11, which is a promiscuous DNA endonuclease, but rather is a reflection of  
mechanisms of homolog pairing and spatial/temporal regulation of Spo11. Although the 
pairing pathways have not been fully elucidate in eukaryotes, there is general consensus 
that most species, including Tetrahymena, initiate pairing through the formation of a 
‘bouquet conformation’.160, 163 This meiosis-specific organization of chromosomes occurs 
as a result of early interactions of homologous centromeres and telomeres. Pairing and 
DSB formation in the genic regions of chromosome occur subsequent to these early 
interactions, as synapses iteratively form along the chromosome arms in a zipper-like 
fashion.164 Importantly, although the major role of Spo11 is to catalyze DSBs in 
euchromatic regions of chromatin, it is present and required for the initial pairing of 
telomeric and centromeric DNA.165 Therefore, heterochromatin formation functions to 
protect the underlying gene-poor repetitive DNA from Spo11 activity at early stages of 
homolog pairing. Given that H3K9me3 is absent from micronuclei, and that the loss of 
H3K27me3 does not alter DSB sites in Tetrahymena, we argue that H3K23me3 underlies 
early meiotic heterochromatin formation, which functions to inhibit DSBs in gene-poor 
DNA.  
  
3.4C   LOSS OF H3K23ME3 EFFECTS SMALL RNA-GUIDED HETEROCHROMATIN 
FORMATION  
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 The bulk of the work in this Chapter focused on the role of H3K23me3 in 
meiosis, which was motivated by our detection of a ~1.5h lag in early conjugating 
ΔEZL3 cells. We also detected a second lag during late conjugation that started with the 
development of new macronuclei and persisted through hour 48 of conjugation. 
Compared to wildtype mating rates, this second lag lasted about 6 hours early in the 
nuclear differentiation stages and extended to at least 18 h by the end of conjugation. 
Cytologically, the lag appeared to occur before the formation of heterochromatic bodies 
in anlagen that directly precede DNA elimination (Figure 23B). Despite the severe lag in 
the formation of heterochromatic bodies, the levels of Pdd1p, H3K27me3 and H3K9me3 
were normal in ΔEZL3 cells. Therefore, our results suggest that the second lag in ΔEZL3 
mating cells occurs during heterochromatin formation in new, developing macronuclei.  
 What is the nature of this second lag? Although there is no detectable H3K23me3 
in new macronuclei at any stage of their development, loss of this mark could affect 
scanRNA activity, which are transcribed in meiotic micronuclei and are critically 
important for macronuclear differentiation. Since the formation of heterochromatic 
bodies are dependent on the proper deposition of H3K9me3 and H3K27me3, as well as 
the engagement of their reader proteins (Pdd3p and Pdd1p, respectively), it is tempting to 
speculate that H3K23me3 contributes to new macronuclei development indirectly by 
affecting scanRNA generation or by regulating Pdd1p, which localizes to micronuclei 
early in conjugation. A thorough comparison of scanRNA from wildtype and ΔEZL3 
cells would provide the necessary evidence to support or to oppose the above hypothesis. 
Moreover, whether ΔEZL3 cells can successfully carry out DNA elimination has not 
been addressed in this work.  
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 A major caveat to the above interpretations is that Ezl3p, although required for 
H3K23 methylation in micronuclei, could have other non-histone targets that affect 
anlagen dynamics later in conjugation. Several studies have recently emerged 
highlighting the ability of so-called histone methyltransferases to modify non-histone 
proteins. Of particular importance to this work, Ezh2 was recently shown to target 
methylation of several non-histone proteins in the cytoplasm of mammalian cells.166  
Therefore, a comprehensive understanding of Ezl3p activity and localization is required 
to effectively parse out its contribution to the phenotypes described above. Notably, our 
efforts to make and antibody against Ezl3p yielded some success for Western blotting 
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CHAPTER 4: EVOLUTIONARY CONSERVATION OF HISTONE 
H3 LYSINE 23 TRIMETHYLATION    
   
4.1   INTRODUCTION 
 Our observations using conjugating Tetrahymena suggested a potentially critical 
role for H3K23me3 during meiosis. To understand the biological significance of this 
modification (and since the H3 tail is highly conserved) in higher eukaryotic homologs of 
H3 (Figure 30A, red underline), we sought to determine if H3K23me3 could be 
detected in mice and C. elegans during meiosis. We first turned to C. elegans, which is an 
excellent model organism to study germline chromatin. Like Tetrahymena, the nematode 
C. elegans is a genetically tractable model organism whose basic physiology and 
developmental stages are well characterized. Studies on the gonads of C. elegans have 
provided important insights into germline development and germ cell differentiation, as 
well as processes regulating mitotic and meiotic checkpoints.156 In adult C. elegans, germ 
cells are essentially organized into two physically and functionally distinct regions Cells 
near the distal tip are maintained as undifferentiated mitotic precursors through the 
signaling of the Notch-like receptor GLP-1. As the cells migrate proximally the GLP-1 
signal weakens triggering the differentiation of mitotic cells into meiotic cells, which 
occurs within a well-defined transition zone (Figure 30B).156, 167   
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 Antibody-based studies of C. elegans gonads have provided a wealth of data that 
speak to the localization of histone PTMs in germline chromatin. Notably, H3K27me3 
and H3Kme3 are uniformly present along the distal-proximal germline axis. Curiously,  
H3K9me2 appears to specifically localized to the inactive X chromosome of females. 
Studies have also shown that loss of the only E(z) homolog of the worm, MES-2, 
completely abolishes H3K27me3 in the gonad. In line with other organisms, γH2A.X is 
detected at the leptotene/zygotene transition zone. To our knowledge, no other histone 
PTM is specifically upregulated at the transition zone.168-170    
 To further examine evolutionary connections between H3K23me3 upregulation 
and meiosis, we analyzed germ cells of mouse testes. Similar to the C. elegans gonad, 
mouse seminiferous tubules are structurally organized into distinct functional regions - 
peripherally located mitotic spermatogonia differentiate into meiotic spermatocytes near 
the lumen (Figure 30C).168 Post-meiotic haploid cells are called spermatids, which 
further differentiate into spermatozoa and get deposited into the lumen. This 
differentiation scheme also involves dramatic changes to chromatin structure, 
exemplified by the formation of a single, DAPI-rich, heterochromatic chromocenter 
containing centromeric and pericentric DNA in spermatids. Notably, chromocenters are 
enriched for H3K9me3 and HP1 isoforms. 




	   94	  
4.2   METHODS 
4.2A   CELL CULTURE AND STRAINS   
C. elegans strains were derived from C. elegans Bristol strain N2 and cultured 
using standard techniques.171 Strain DG2389 glp-1 (bn18lf) was cultured at the 
permissive temperature (15 °C) and shifted to 25 °C for 18 hours to interfere with Notch 
signaling and induce meiotic differentiation of germ cells. Strain GC833 glp-1(ar202gf) 
was grown at 25 °C from L1 larvae to adulthood to continuously expose germ cells to 
high levels of Notch signaling. To analyze loss of the C. elegans Enhancer of zeste 
homolog, we used the mes-2(bn11) homozygous mutant. To analyze loss of mes-4 
function, wildtype C. elegans were treated with mes-4(RNAi) from L1 larvae to adulthood 
by a standard feeding protocol.172  
The mouse tissues were obtained from wildtype C57BL/6 surplus male mice that 
were scheduled for termination under IACUC protocol and provided to our laboratory 
following euthanasia. This procedure was reviewed and approved by Johns Hopkins 
Animal Care and Use Committee and was performed in accordance with the NIH Guide 
for the Care and Use of Laboratory Animals. 
 
4.2B   WESTERN BLOT AND INDIRECT IMMUNOFLUORESCENCE ANALYSES  
 SDS-PAGE and Western blotting were performed as described above (Chapter 2, 
Methods). Rabbit polyclonal antibodies used in Western blots included: α-H3 (1:75,000; 
ab1791; Abcam) and α-H3K23me3 (1:100; made in this study).  
Worm immunofluorescence staining - adult C. elegans hermaphrodites were 
washed in PBS and germlines were dissected on poly-L-lysine treated slides, covered 
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with a coverslip to ensure attachment to slide, and snap-frozen on aluminum blocks on 
dry ice. The samples were fixed for 1 minute in 100% methanol at -20 °C, followed by 5 
minutes in 2% EM grade paraformaldehyde in 100 mM K2HPO4 pH 7.2 at room 
temperature. The samples were blocked for at least 30 minutes with PBS containing 0.1% 
BSA and 0.1% Tween-20 (PBTw) with 10% Normal Goat Serum. Primary antibodies 
were diluted in PBSTw as follows: rabbit α-H3K23me3 (1:70); mouse α-H3K9me3 
(1:100; #39285; Active Motif); mouse α-H3K27me3 (1:100; #39536; Active Motif); 
mouse α-H3K4me3 (1:250; ab1012; Abcam). Secondary antibodies were goat α-rabbit or 
α-mouse conjugated with Cy3 or Alexa-488 diluted at 1:200 in PBTw (Jackson 
Immunoresearch and Invitrogen). Primary antibody incubations were overnight at 4 °C; 
secondary antibody incubations were for 2 hours at room temperature. For peptide 
competition experiments, α-H3K23me3 was incubated with 5 µg / mL of indicated 
peptides for 1 h on ice, and immune complexes were removed by centrifugation for 10 
min at 14,000 rpm. Preabsorbed primary antibodies were applied to the tissue samples for 
1 h at room temperature followed by secondary antibody incubation for 1 h at room 
temperature. Before imaging, DNA was counterstained with DAPI. 
Mouse immunofluorescence staining: testes of 7 week old male C56BL/6 mice 
were dissected and detunicated in PBS, fixed in 2% paraformaldehyde in PBS for 3 hours 
at 4 C, equilibrated into 30% sucrose solution overnight at 4 °C, embedded in OCT, and 
then frozen. Seven micron-thick sections were cut, adhered to slides, baked at 50 C for 45 
minutes, and permeablized in PBS/0.05% Triton-X100. Sections were blocked for 30 
minutes in PBS containing 0.05% Triton-X100, 10% normal goat serum and 0.3% BSA. 
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Further immunostaining procedures were carried out as described above for the worm 
samples.  
Microscopy for worm and mouse slides: confocal images were acquired with a 
Cascade QuantEM 512SC camera (Photometrics) attached to a Zeiss Axioimager 
microscope with Yokogawa spinning disk confocal scanner and Slidebook software 
(Intelligent Imaging Innovations). Maximal-intensity projections encompassing a single 
layer of nuclei were generated by the Slidebook software. Image processing was 
performed in Adobe Photoshop CS4. 
 
4.2C   HISTONE EXTRACTION FROM C. ELEGANS EMBRYO NUCLEI  
 Nuclei from embryos were isolated following a previously described method. 173   
Once isolated, nuclei were pelleted and resuspended in 5X pellet volume 0.4 N H2SO4 
and rotated for 2 h at 4 °C. Following centrifugation for 10 min at 10000 g, histones in 
the supernatant were acid-precipitated by 100% trichloroacetic acid (TCA) at a dilution 
factor of 1:4 (TCA: supernatant; final 20% TCA) for 1 h on ice. TCA precipitates were 
pelleted by centrifugation for 10 min at 10,000 g, washed 2X with ice-cold acetone, 
resuspended in water, and stored at -80 °C. 
 
4.3   RESULTS  
4.3A   H3K23ME3 IS CONSERVED IN NEMATODES  
In collaboration with Dr. Ekaterina Voronina (University of Montana, Missuoula, 
MT; formerly a postdoctoral fellow in Dr. Geraldine Seydoux’s laboratory, Johns 
Hopkins University, Baltimore, MD), we initially examined nuclear extracts from whole 
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C. elegans embryos, since their nuclei could be easily purified with respect to adult 
worms, making possible a direct comparison of H3K23me3 levels on H3 between C. 
elegans and Tetrahymena. Comparative Western blot analysis of whole-worm nuclear 
extracts showed that H3K23me3 was indeed present on C. elegans H3, although at a 
much lower level than that found on Tetrahymena micronuclear H3F (Figure 31A). 
Given that H3K23me3 is present in C. elegans, we next wanted to determine if 
this mark is upregulated during meiosis. By indirect immunofluorescence, H3K23me3 
was nearly absent in the mitotic region of the gonad, although a small number of mitotic 
nuclei in this region were positive for the PTM (Figure 31B). In striking contrast, 
H3K23me3 staining became robust in meiotic cells within the gonad, beginning at the 
leptotene/zygotene transition zone that marks meiotic entry, and plateauing through the 
rest of meiotic prophase (Figure 31B). Compared to H3K27me3, H3K9me3, and 
H3K4me3 distribution in the gonad, H3K23me3 was the only PTM that became enriched 
as germ cells entered the transition zone (Figure 32A-C). Under high magnification, 
H3K23me3 and other PTMs also exhibited comparatively different sub-nuclear staining 
patterns within meiotic cells (Figure 32A-C). Notably, H3K23me3 appeared relatively 
punctate across the entire nucleus rather than being enriched on either the autosomes (like 
H3K4me3) or the silenced Xs (like H3K27me3) (Figure 32A,C). 174, 175 Importantly, our 
peptide competitions showed that α-H3K23me3 is highly specific for H3K23me3 in the 
C. elegans gonad (Figure 33).  
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4.3B   H3K23ME3 IS STRONGLY LINKED TO MEIOSIS IN NEMATODES  
 We further examined the correlation between H3K23me3 and meiotic entry in C. 
elegans using mutants of the Notch-like receptor GLP-1, which maintains the 
proliferative state (mitotic) of germline stem cells.156, 176 As expected, in the GLP-1 loss-
of-function mutant glp-1(lf), which undergoes early differentiation of mitotic cells and 
early entry into meiosis, we observed a shift of the H3K23me3 signal towards the distal 
tip of the gonad (Figure 34A-B). Remarkably, in the GLP-1 gain-of-function mutant glp- 
1(gf) which prevents entry of mitotic germ cells into meiosis and causes their 
proliferation, H3K23me3 levels were significantly reduced throughout the gonad (Figure 
34C). Moreover, Western blot analysis of glp-1(gf) whole-worm-extracts showed that 
H3K23me3 levels are also dramatically reduced on an organismal level, further 
indicating the vast majority of H3K23me3 signal in adult C. elegans is confined to 
meiotic germ cells (Figure 34D). By contrast, H3K9me3 and H3K27me3 levels were 
intact, and perhaps even upregulated, in glp-1(gf) whole-worm extracts (Figure 35). 
Notably, by our immunofluorescence staining we noticed that cells of the gut and head 
regions were also intensely staining with this antibody (data not shown).    
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4.3C   MES-2 AND MES-4 ARE NOT THE WRITERS FOR H3K23ME3 IN NEMATODES  
Since the SET domain of Tetrahymena Ezl3p is relatively similar to Enhancer of 
zeste, we examined whether the only Enhancer of zeste homolog present in C. elegans, 
the H3K27 methyltransferase MES-2, could also methylate H3K23. As expected, in the 
gonad of mes-2 knockout strains, H3K27me3 was completely undetectable (Figure 36A). 
In contrast, H3K23me3 remained present in meiotic cells, and surprisingly, H3K23me3 
levels within the mitotic germ cell region increased (Figure 36A). Additionally, we 
investigated H3K23me3 levels following RNAi-mediated knockdown of MES-4, an NSD 
homolog known to antagonize MES-2 in the germline.177 Similar to mes-2 knockouts, 
H3K23me3 remained detectable in mitotic and meiotic regions of the mes-4(RNAi) 
germline (Figure 36B). MES-2 and MES-4 regulate gene expression in the germline, and 
their disruption may have pleotropic effects that include alteration of pathways regulating 
H3K23me3.177 Nevertheless, our data suggest neither MES-2 nor MES-4 are exclusively 
responsible for H3K23me3 in the C. elegans gonad. Similarly, H3K23me3 levels were 
intact in strains deficient in SET-2, SET-12, MET-1, MET-2, and MET-10 
methyltransferases, which were tested because of the similarity of their SET domain to 
that of Tetrahymena Ezl3p (Figure 37).  
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4.3D   H3K23ME3 IN CONSERVED IN GERM CELLS OF MICE  
 Much like C. elegans, cell division programs of mouse germ cells are coupled to 
differentiation and are highly compartmentalized. Indirect immunofluorescence staining 
of mouse testes showed that α -H3K23me3 was initially detected in spermatocytes that 
were also positive for SCP3, a recombination protein expressed during meiotic entry/ 
leptotene (Figure 38). Peptide preincubations revealed that α -H3K23me3 was specific 
for H3K23me3 in mouse germ cells (Figure 39). Notably, as germ cells differentiated 
into spermatids, the H3K23me3 signal became increasingly confined to a tight focal 
subdomain within highly condensed chromocenters, which contain pericentric 
heterochromatin (Figure 38, yellow arrowheads).169 Together with our previous data, 
these results suggest the upregulation of H3K23me3 during meiosis is conserved among 
Tetrahymena, C. elegans, and mice, and the enrichment of H3K23me3 within pericentric 
heterochromatin is conserved between mice and Tetrahymena. 
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4.3E   H3K23ME3 IS PRESENT IN THE DEVELOPING BRAIN OF MICE  
 While performing the immunofluorescence assays using α -H3K23me3 in C. 
elegans, we noticed that some somatic cells of the head and gut regions were also 
strongly stained. The positive stain at the head region suggested that H3K23me3 could be  
present in neurons. Prompted by these observations we proceeded to test for the presence 
of H3K23me3 in adult and embryonic mouse brain tissue. As shown in Figure 40A, we 
detected H3K23me3 in the embryonic brain tissues, but not in adult brain tissues by 
Western blot analysis (in collaboration with Sarven Sabuncyan, JHMI, Baltimore, MD). 
Surprisingly, the staining profile also indicated that H3K23me3 levels dramatically 
increase during embryogenesis (from E18.5 to E20.5) and sharply decline during 
adulthood. By comparison, H3K27me3 levels were relatively stable at the embryonic 
stages. Control tissue samples of embryonic and adult tissue also highlighted the fact that 
H3K23me3 is highly enriched in brain tissues. Taken together, these results showed that, 
in addition to the mouse germline, H3K23me3 is also present and upregulated in the 
mouse brain during embryogenesis, when neurogenesis at the cortical plate is peaking.  
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 During mouse embryogenesis, the cortical plate begins to develop at the E12.5 
gestational period. At this stage, progenitor cells located near the ventricular zone 
differentiate as they migrate towards the cortical zone to give rise to the neurons that 
comprise the new and thickening cortical plate.178 This process continues up to the point 
of birth.178 The increase in H3K23me3 we detected by Western blotting followed the 
same dynamics as neurogenesis in the cortical plate, suggesting a possible overlap in 
function. To determine whether H3K23me3 is involved in the formation of the cortical 
plate, we performed immunofluorescence analysis of brain sections of embryonic mice at 
E14.5 (in collaboration with Drs. Arnab Kundu and Andre Levchenko, JHMI, Baltimore, 
MD). Remarkably, we found that H3K23me3 was highly enriched in cortical neurons, 
and only few neurons near the ventricular zone were positive for this mark (Figure 40B).  
These results indicate that H3K23me3 levels are upregulated during neuronal 
differentiation.  
 Next, to interrogate the dynamics of H3K23 trimethylation during neurogenesis, 
we employed an in vitro model of differentiation using human embryonic stem cells (in 
collaboration with Valentin Sluch and Dr. Don Zack, JHMI, Baltimore, MD). Using 
appropriate chemical signals, hESCs can be made to differentiate into neurons. We 
viewed this as an exciting opportunity to not only ask whether H3K23me3 is present in 
human neuronal samples, but also to develop an in vitro cell line that contains 
H3K23me3 and would inform and facilitate future biochemical experiments. To date, no 
other somatic cell culture lines that we tested contained H3K23me3, including Cos7, 
HEK293, Panc-1, CaCo-2, primary lymphoma, and HeLa cells (data not shown). Thus, 
we induced neurogenic differentiation in hESCs and collected whole-cell-extracts to 
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analyze by Western blotting. Our results show that H3K23me3 levels, virtually 
undetectable in hESCs, were robustly upregulated during neurogenesis (Figure 41). This 
increase coincided with the appearance of clipped H3 species previously shown to occur 
during differentiation of mouse embryonic stems cells (ESCs).179 Given that the major 
clipping site (alanine 21) of histone H3 in mouse ESCs is proximal to H3K23, these 
findings suggest a potential overlap in the functions of clipping and H3K23me3.  
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4.4   DISCUSSION  
4.4A   H3K23ME3 IS A CONSERVED PTM ENRICHED IN GERM CELLS  
 Given that the histone H3 N-terminus is highly conserved across eukaryotic 
evolution, a histone PTM specific antibody may be used to assess the degree of  
conservation of that mark. In this work, we generated an antibody specific for 
H3K23me3 and showed that this mark is conserved in Tetrahymena, C. elegans and 
mice. Additionally, we found that H3K23me3 is upregulated in meiotic chromatin of 
these species. We extend our observations in Tetrahymena to propose that H3K23me3 
plays an integral and evolutionary conserved role in protecting genomic integrity in germ 
cells, suggesting a previously unappreciated heterochromatin-forming pathway helps 
limit DSB formation during meiosis.  
 Mass spectrometric evidence indicates that trace levels of H3K23me3 exist in 
mammalian somatic cells such as mouse embryonic fibroblasts, mouse embryonic stem 
cells, and HeLa cells.55, 74 Given its low levels, we were unable to detect H3K23me3 in 
mammalian somatic cells by Western blot or immunofluorescence analyses (data not 
available). As DSB formation and recombination can occur in mitotic cells, albeit in 
dramatically reduced rates, the presence of H3K23me3 might serve a similar function in 
mitotic cells as its proposed function in meiotic cells. Still, we were able to detect high 
levels of H3K23me3 in mouse germ cells and embryonic brain tissues, indicating 
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4.4B   H3K23ME3 AND H3K9ME3 ARE FUNCTIONALLY DISTINCT  
 Previous studies concerning H3K23 methylation have hinted at a functional 
overlap between H3K23me3 and H3K9me3. Specifically, two studies to date have shown 
that the H3K9me3 reader, HP1, can bind to H3K23me3 in vitro.55, 74 This observation 
enabled the authors to conclude that H3K23me3 is a heterochromatin-associated 
modification. Moreover, H3K9me3 plays a crucial role in inhibiting meiotic DSBs and 
crossover events through compaction of specific genomic regions, like chromocenters, 
thus limiting Spo11 access.122, 180 Our findings that H3K23me3 is associated with 
chromocenters in mouse spermatocytes and with centromere-proximal regions in meiotic 
micronuclei of Tetrahymena are in agreement with a potential overlap in H3K9me3 and 
H3K23me3 activities.  
 Despite the striking similarities of H3K9 and H3K23, we have amassed several 
lines of evidence that suggest H3K9me3 and H3K23me3 are sufficiently distinct in 
function and localization. Our work in Tetrahymena clearly show: 1) H3K9me3 is absent 
altogether from Tetrahymena micronuclei and the loss of the other heterochromatin-
associated mark, H3K27me3, does not lead to mislocalized DSBs; 2) there is a 
pronounced timing differential between the occurrence of H3K23me3 and H3K9me3 
during conjugation; and 3) H3K23me3 is not detected in developing new macronuclei, 
which are enriched for H3K9me3. The difference between the appearance of H3K23me3 
and H3K9me3 also suggests that α-H3K23me3 is specific for H3K23me3 rather than the 
H3K9me3 epitope. Most importantly, our immunofluorescence staining of mouse testis 
showed that H3K23me3 was restricted to the central region of the chromocenters. This 
staining profile is clearly different from the H3K9me3 staining profile, which overlaps 
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with the entire chromocenter.170, 181 This suggests that H3K23me3 is associated with a 
subset of DNA elements located within H3K9me3-enriched chromocenters. As several 
proteins, like HP1 isoforms, have been shown to bind to H3K23me3 in high-throughput 
and in vitro assay, we speculate that these or as yet unknown proteins/complexes 
specifically interact with H3K23me3 in vivo, perhaps in the presence of H3K27me3, to 
mediate protection of the germline genome from Spo11 access and homologous 
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A.1    DEVELOPMENT OF A TECHNIQUE TO IMPROVE THE 
 STUDY OF PROTEIN-PROTEIN INTERACTIONS IN 
 TETRAHYMENA 
 
 Stable isotope labeling by amino acids in cell culture (SILAC) culture has proven 
to be a highly useful technique in circumventing inherent technical difficulties associated 
with the study of proteins. Among these, the co-purification of non-specific interacting 
proteins during co-immunoprecipitation assays is one of the most formidable obstacles 
since it often masks specific and stable protein-protein interactions that occur in vivo. I-
DIRT (Isotopic Determination of Interactions as Random or Targeted) was developed to 
improve weak signal-to-noise ratio typical of antibody-based protein complex 
purifications. A central feature of this protocol is that parallel cultures are grown in 
‘heavy’ (13C Arg/Lys) or ‘light’ (12C Arg/Lys) labeled media. The light culture contains 
cells that express a tagged protein-of-interest. Cells from both cultures are flash frozen to 
maintain protein-protein interactions and subjected to cryolysis (- 80 °C) using a mixer 
mill. Equal amounts of light and heavy lysates are then mixed, resuspended in buffer, and 
immunoprecipitated using a tag- specific antibody. Thus, stable interaction with the tag-
protein yields a distinct MS signature designated by the absence of heavy labeled 
peptides.   
 I sought to adapt the I-DIRT procedure for Tetrahymena to aid in the unbiased 
and unambiguous identification of protein complexes in this model organism. To 
determine if I-DIRT is feasible in Tetrahymena, I first tested whether these cells are 
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amenable to metabolic labeling during vegetative growth. A minimal media was 
generated following the formulation from a previous study183; however to make heavy 
media, light lysine was replaced with 13C labeled lysine providing a 6 Dalton increase in 
overall mass. As shown in Appendix Figure 1, heavy isotope incorporation was highly 
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A.2    PDD1P INTERACTOME    
 
 Programmed DNA degradation protein (Pdd1p) is a chromodomain-containing 
protein that binds to H3K27me3 (and H3K9me3) in developing macronuclei during 
conjugation. This interaction is required for the successful elimination of micronuclear-
limited sequences, including transposable elements, and is regulated by the upstream 
activities of piRNA-like scanRNA and E(z) homolog Ezl1p. Immunofluorescence 
staining has revealed that Pdd1p is uniformly distributed in new developing macronuclei 
at hour 9 of conjugation. However, by hour 12, the Pdd1p enriched chromatin forms 
cytologically distinct, heterochromatic bodies where DNA elimination is thought to 
occur. This process involves several proteins, but whether they directly bind to Pdd1p is 
not known, and the exact role of Pdd1p is not entirely clear. To date, no study has 
successfully identified proteins, including histones, that co-purify with Pdd1p in vivo.  
 Since previous attempts using standard lysing and Co-IP techniques have failed to 
yield proteins that interact with Pdd1p, we utilized a new technique at that time that is 
highly stringent in terms of lysing cells but favorable for maintaining protein-protein 
interactions. This method, which lyses cryogenically frozen cells, was initially developed 
to lyse yeast. We found that this cryolysis technique completely lysed Tetrahymena cells 
after just six rounds of pulverizing by a mixer mill (30 hertz, 3 min/round). The resulting 
frozen cell powder was resuspended in binding buffer (containing 300 mM salt), 
homogenized by drill, and then subjected to standard co-immunoprecipitation procedures. 
Using an anti-HA tag antibody, we performed co-immunoprecipitation analysis of a 
control wildtype strain and strain that expresses a HA-tagged Pdd1p protein. Remarkably, 
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we found that the new lysing conditions yielded several co-purifying proteins. 
Importantly, we found that Pdd1p pulls down seemingly equimolar levels of histone 
proteins as determined by Coomassie staining of a SDS-PAGE gel (Appendix Figure 2). 
We cut out several of these bands and subjected them to mass spectrometric identification 
in collaboration with Dr. Alan Tackett (University of Arkansas, Little Rock, AR). We 
identified several proteins associated with gene regulation Appendix Figure 2. Of note, 
we identified one peptide corresponding to Twi1p, the argonaute protein that binds to 
complimentary scanRNA and targets micronuclear-limited sequences for 
H3K9me3/H3K27me3 in new developing macronuclei. Moreover, we found that altering 
the salt concentration in the initial binding buffer leads to dramatic changes in the amount 
and identity of the co-puride proteins. These analyses also reveal that histones are best 
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A.3    A PROTOCOL FOR STUDYING MULTIPLY ACETYLATED 
 HISTONES 
 
Citation: Papazyan, R. & Taverna, S. D. Separation and purification of multiply  
  acetylated proteins using cation-exchange chromatography. Methods Mol.  
  Biol. 981, 103-113 (2013). 
 
Title:   Separation and purification of multiply acetylated proteins using cation- 
  exchange chromatography 
 
Abstract:  High performance liquid chromatography (HPLC) is extremely useful for  
  the study of proteins and the characterization of their post-translational  
  modification. Here we describe a method that utilizes cation-exchange  
  HPLC to separate multiply acetylated histone H3 species on the basis of  
  their charge and hydrophilicity. This high-resolution method allows for the 
  separation of histone H3 species that differ by as few as one acetyl group,  
  and is compatible with subsequent analysis by a variety of techniques,  
  including mass spectrometry and western blotting.    
 
1. Introduction 
Dynamic protein acetylation is known to impart key functional changes in 
biological systems, in particular, acetylation of eukaryotic histone proteins helps govern 
transcriptional competency of the associated DNA. It is increasingly appreciated that 
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acetylation can reside at multiple sites on the same histone polypeptide, and can even 
occur together with other small covalent post-translational modifications (PTMs) like 
methylation and phosphorylation. Specific combinations of such PTMs likely “code” for 
a variety of integrative chromatin-templated processes. However, the mechanistic basis of 
this regulation is poorly understood, in part because detection of multiple PTM states is 
complicated. For example, antibody-based recognition of PTMs is often dependent on 
epitope accessibility, which can vary depending on the modification state of surrounding 
residues. Fortunately, mass spectrometry methodologies have recently emerged that 
permit relatively unbiased PTM analysis on long stretches of amino acids or even intact 
proteins, although the complexity of PTM states usually necessitates extensive front-end 
purification to be suitable for such approaches (1,2).  
While gel-based systems including acid-urea gel electrophoresis can be used to 
resolve acetylated (and phosphorylated) protein isoforms, the amount of material purified 
is relatively small and is in a form that is not compatible with limited proteolytic 
treatment necessary to utilize the mass spectrometry approaches referred to above. These 
deficiencies are remedied by cation-exchange HPLC. Under certain conditions, cation-
exchange columns, like polyCAT A, permit separation of protein isoforms by exploiting 
their hydrophilic and electrostatic differences (3-5). For example, protein acetylation 
decreases positive charge and hydrophilicity, which contribute to the superior resolving 
power of polyCAT A chromatography. Furthermore, this chromatographic approach can 
also be performed on a preparative scale, yielding amounts of protein that are compatible 
with subsequent analysis by mass spectrometry and western blotting (6). 
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Below we describe our approach to separate and purify distinctly acetylated 
isoforms of histone H3 from the ciliated protozoan Tetrahymena thermophila by using 
polyCAT A-based chromatography. We start with highly-purified histone H3 from 
Tetrahymena which contains a complex mixture of acetylation states ranging from no 
acetylation to five (and possibly more) acetylated lysines. We treat this purified H3 with 
acetic anhydride (Ac2O) to generate hyperacetylated isoforms in vitro.  The 
hyperacetylated and endogenous H3 samples are independently applied to the polyCAT 
A column and eluted over a steep salt gradient. The concentrations of salt required to 
elute hyper- and endogenously acetylated H3 isoforms are used to demarcate elution 
conditions for all possible acetylated H3 isoforms. Endogenous H3 is then reapplied to 
the column and eluted using the truncated range of salt concentrations and an extended 
run time, thus achieving maximal resolution among acetyl isoforms. Lastly, samples are 
desalted by reversed phase-HPLC (RP-HPLC) and stored for subsequent analysis by 
mass spectrometry and western blots. Although we resolve histone H3 acetyl states in this 
protocol, this methodology can be adapted for many other acetylated proteins as well.  
 
2. Materials 
All commercially available solutions and reagents should be analytical grade. Water used 
to prepare solutions should be ultrapure and highly deionized. Additionally, any solution 
made for HPLC should be purified using at least a 0.45-micron filter and degassed prior 
to injection into the column. 
2.1 In vitro acetylation of proteins 
1. Acetic anhydride (Ac2O) 
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2. Methanol (MeOH).  
3. 2 x Reaction buffer: 100 mM ammonium bicarbonate (NH4HCO3, m.w. = 
79.05). Dissolve 79 mg in 10 mL of water and do not adjust the pH (see Note 
1). 
4. RP-HPLC purified protein dissolved in water (~2 mg/mL) (see Note 2). 
5. Microcentrifuge tubes. 
6. Speed-vac centrifuge.  
2.2 Desalting by Reversed Phase-HPLC 
 1. HPLC pump and fraction collector. 
2. C8 column (220 x 4.6 mm, RP-300, #0711-0059, Perkin Elmer, Waltham, MA, 
USA). 
3. Acetonitrile (CH3CN), HPLC grade. 
 4. Trifluoroacetic acid (TFA).  
 5. Graduated cylinders, 1 L and 100 mL. 
 6. Magnetic stirrer, stir bars, and 1 L suction flasks. 
7. Kontes vacuum filtration assembly (#XX1504700, Fisher Scientific, Fair Lawn, 
NJ, USA). 
8. Durapore PVDF membrane filters 0.45 microns (#HVLP047000, Millipore, 
Billerica, MA, USA). 
9. 1 mL Hamilton syringe equipped with blunt end needle point.  
2.3 PolyCAT A chromatography buffers 
1. Phosphate buffer: Stock solution is made by mixing appropriate amounts of 
NaH2PO4 (Sodium phosphate monobasic, solution 1) and Na2HPO4 (Sodium 
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phosphate dibasic, solution 2) to obtain the final buffer at pH 7. Start by 
making 1 M stocks of each solution. Dissolve 6.9 g of monobasic NaH2PO4-
H2O (m.w. = 138) in water to a final volume of 50 mL (Solution 1) and 7.1 g of 
dibasic Na2HPO4 (m.w. = 142) in water to a final volume of 50 mL (Solution 
2). Shake both solutions vigorously to help dissolve. While stirring 50 mL of 
solution 2, adjust to pH 7 by slowly (1 mL at a time) adding solution 1. Store 
the 1 M Phosphate Buffer pH 7 at room temperature.    
 2. Urea [CO(NH2)2].  
 3. Dithiothreitol (DTT): 1 M solution dissolved in water (see Note 3). 
 4. Sodium chloride (NaCl). 
5. Bio-Rex MSZ 501 [D] deioninzing resin (#142-7425, BioRAD, Hercules, CA, 
USA). 
6. Gravity column (#732-1010, BioRAD, Hercules, CA, USA).  
7. Two 500 mL graduated cylinders. 
8. Magnetic stirrer, stir bar, and 1 L flask. 
2.4 PolyCAT A column chromatography components 
 1. HPLC pump and fraction collector. 
2. PolyCAT A column (200 X 4.6 mm, 5 µm, 1000Å, PolyLC, Columbia, MD, 
USA) (see Note 4 and Note 5). 
3. 1 mL Hamilton syringe equipped with blunt end needle point.  
4. Dot blot apparatus (#170-6545, BioRAD, Hercules, CA, USA). 
5. PVDF membrane.  
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6. Necessary reagents and instructions for immunodetection are described in 
reference 6.  
 
3. Methods 
3.1 In vitro acetylation of proteins  
1. Make 50 µL of acetylation buffer by mixing 12.5 µL of acetic anhydride with 
37.5 µL of methanol (see Note 6). 
2. In a separate microcentrifuge tube, mix 10 µL 2X reaction buffer and 10 µL of 
protein (2 mg/mL) (see Note 7). 
3. Combine the two solutions (70 µL final volume) and briefly mix by gentle 
tapping.  
4. Incubate at room temperature for 30 min. 
5. Stop the reaction by drying with a speed-vac centrifuge (see Note 8). 
6. Store dried samples at -20°C. 
7. The extent of acetylation can be tested by mass spectrometry, immunoblot assays, 
or acid-urea gels after desalting the samples following the procedures in section 
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3.2 Desalting by reversed-phase HPLC  
1. Prepare mobile phase for RP-HPLC: 1 L solution A: 5% acetonitrile, 95% water, 
0.1% TFA; and 1 L solution B: 90% acetonitrile, 10% water, 0.1% TFA (see Note 
9). 
2.  Vacuum filter both chromatography solutions using a 0.45 micron PVDF filter 
(see Note 10).  
3. Transfer solutions into clean 1 L suction flasks with stir bar and stir at medium 
speed for 10 minutes under vacuum to degas each buffer.  
4. Equilibrate the C8 column with 10 mL of solution A at a flow rate of 0.8 mL/min. 
5. Take dried samples from section 3.1 and resuspend in 200 ul of solution A by 
vortexing. 
6. Spin down >15,000 x g for 5 min to pellet any particulates. 
7. Load into Hamilton syringe, inject the sample in the HPLC machine and run the 
chromatography method at 0.8 mL/min according to Appendix Table 1 (see Note 
11). 
8. Record absorbance at 214 nm and collect relevant fractions.  
9. Dry down fractions by speed-vac centrifugation.  
10. Once dried, the samples can be stored at -20°C.   
3.3 Preparation of the mobile phases for polyCAT A chromatography 
These solutions are made fresh before use and discarded at the end of each day. A 
flow-chart for the procedures in this section and the final concentration of the 
components for the mobile phases are provided in Appendix Figure 5. 
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1. In a 1 L flask, dissolve 192.2 g of urea (m.w. = 60.06) in 230 mL of water. Stir at 
room temperature until the urea completely dissolves (see Note 12). 
2. Remove ions from the urea solution by adding 1-5 g of deionizing resin. Deionize 
for an hour while stirring. Add more resin as needed (see Note 13).  
3. Remove the resin by passing the urea solution through a gravity column. Collect 
the flow through in a 500 mL graduated cylinder.  
4. While stirring on a magnetic plate add 9.2 mL of 1 M Phosphate buffer to the 
flow through.  
5. Add 200 µL of 1 M DTT.   
6. Adjust the volume to 380 mL with water.  
7. Split the solution evenly into two graduated cylinders (190 mL in each cylinder). 
In the first cylinder add 10 mL water and label this “solution A” for polyCAT 
chromatography.  
8. While stirring the second cylinder dissolve 11.68 g of NaCl (m.w. = 58.44) to 
obtain a final concentration of 1 M NaCl and label this as solution “B” for 
polyCAT chromatography. Adjust the final volume of solution B to 200 mL. 
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3.4 PolyCAT A chromatography 
1. Equilibrate the column with at least 10 mL polyCAT solution A or until 
absorbance at 230 nm stabilizes. Use a flow rate of 0.4 mL/min for this step and 
all steps in the chromatography protocol (see Note 5). 
2. While equilibrating, resuspend dried sample from Section 3.2 in 200 µL polyCAT 
solution A by vortexing for several seconds (see Note 14). 
3. Pellet any particulates in the tube by centrifuging >15,000 x g for 5 min. 
Immediately after centrifugation, load the sample into a Hamilton syringe fitted 
with an appropriate blunt needle point designed for injections into HPLC 
machines.   
4. Inject the sample into the HPLC machine and follow the chromatography protocol 
outlined in Appendix Table 2. Detect the presence of protein by constantly 
measuring absorbance at 230 nm (see Note 15). Collect fractions every 2 min (0.8 
µL fraction volume) during the first 110 min of the run (see Note 16). Retention 
time increases as the number of acetylated sites on the protein decrease. For 
example, hyperacetylated proteins will elute before hypoacetylated species.  
5. To obtain an optimal range of elution conditions repeat procedures 1-4 above 
using RP-HPLC purified protein samples that are not treated with Ac2O. Compare 
all fractions from the two polyCAT A chromatography runs by using a dot blot 
apparatus (load ~10% of each fraction) followed by immunodetection (Appendix 
Figure 6A). The optimal salt concentration range will encompass fractions that 
include hyperacetylated (Ac2O treated) and endogenously acetylated species.  
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6. Inject more sample into the polyCAT A column and adjust the elution gradient by 
increasing the time of elution within the newly defined elution range, as described 
in Fig. 3B (see Note 17). Successful optimization of elution conditions will yield 
individual peaks on the chromatogram that differ by one acetyl group (Appendix 
Figure 6B and see Note 18). 
7. Desalt each relevant fraction by thawing them individually and injecting them 
onto a RP-HPLC column using the desalting procedures above followed by 
drying to completion using a speed-vac centrifuge. Dried fractions may be stored 
in -80°C.  
8. Desalted samples may be analyzed by gel electophoresis or mass spectrometry 
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4. Notes 
1. Due to the volatility of ammonium bicarbonate we recommend making fresh 
solution each time before use.  
2. We obtain purified histone H3 by following the nuclear preparation, acid 
extraction, and RP-HPLC purification protocols described in Shechter et al. (7). 
During nuclear preparation, we try to preserve endogenous protein acetylation by 
including 10 mM butyric acid, an HDAC inhibitor, in buffers.  
3. To make 1 M stock solution, dissolve 1.54 g of DTT (m.w.= 154.25) in water to a 
final volume of 10 mL. Filter, divide to 1 mL aliquots, and store in -20C.  
4. The specifications of the column will vary depending on the mass and properties 
of the protein being studied. Contact the manufacturer for additional help with 
selecting the proper column.     
5. PolyCAT A column performance is significantly enhanced when prewashed with 
40 mM EDTA-2Na overnight using a slow flow rate (0.25mL /min). Do not 
adjust the pH of this solution while dissolving and remember to filter purify the 
solution prior to passing it through the column. Wash with 10 mL filtered water 
and proceed to equilibrating the column with “solution A”. 
6. The in vitro acetylation protocol was adapted from reference 8.  
7. This procedure is used to acetylate 20 µg of protein. If more acetylated protein is 
desired adjust the volume of the final reaction as needed and keep the same ratio 
between the acetylation and reaction buffers.  
8. The acetic anhydride reaction is very fast and when using a speed-vac to dry the 
samples, the reaction yields fully acetylated proteins. In addition to lysines, this 
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treatment yields acetylated N-termini.  
9. Prepare appropriate volumes of acetonitrile and water in separate graduated 
cylinders prior to mixing. Upon mixing the actual volume (~980 mL) will be less 
than the expected volume (1000 mL) due to entropy changes. Carefully add TFA 
in the end and proceed to filtration.  
10. This critical step is required for all solutions used in HPLC. Removal of 
particulates extends the life of the column and minimizes clogging during a run.  
11. Prior to this step you can save time by running a pure recombinant sample to 
determine the proper conditions and time of elution of the protein being studied. 
In general, acetylation or other small PTMs do not dramatically affect the column 
retention time of proteins, so hypoacetylated proteins will elute in the same 
fractions as hyperacetylated proteins using RP-HPLC. If recombinant protein is 
not available, collect fractions over the entirety of the initial run. After 
determining the elution time of the sample, the fraction collection window can be 
narrowed.  
12. Do not heat the urea solution to dissolve because heating promotes the breakdown 
of urea into ions that lead to chemical modification (carbamylation) of the 
proteins being studied.  
13. Deioninzing the urea solution is critical to eliminate carbamylation of proteins 
and to facilitate the interaction of the protein with the column. This resin contains 
a colorimetric indicator that turns gold or clear when saturated with ions. 
Continue adding resin until some of the resin remains blue (1-5 g).  
14. Samples injected into the column should be free of salts. When possible, we 
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recommend drying the protein sample using a speed-vac centrifuge and 
resuspending it in polyCAT solution A prior to column injection.   
15. When possible, absorbance at 230 nm should be recorded for polyCAT A 
chromatography of histones, because urea saturates the 214 nm signal.  
16. This is not necessary for subsequent runs, but for the initial run we recommend 
collecting all fractions to help determine the extent of binding and retention in the 
column.  
17. While we narrowed the salt concentration to optimize elution conditions, the 
samples were still resuspended in polyCAT A “solution A” containing no salt. 
The details of the optimized polyCAT A chromatography protocol is highlighted 
in the caption for Appendix Figure 6B. In general, samples should be injected 
onto the column using a solution that lacks salt. The presence of salt will disrupt 
the retention time and resolution of the analyte.  
18. Following polyCAT A chromatography, we highly recommend washing the 
column with filtered water (>20 mL) followed by a total system clean of the 
HPLC following, especially if the same HPLC machine will be used for 
subsequent desalting steps by RP-HPLC. Mixing the mobile phases from each 
type of chromatography may cause precipitation of salts and significant damage 
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A.4    CONTRIBUTIONS TO SEQUENCING THE MICRONUCLEAR 
 GENOME 
 The draft sequence of the macronuclear genome of Tetrahymena was published in 
2006.112 This study revealed that the genome size is approximately 104 megabases and is 
composed of 225 chromosomes. As expected, their findings also confirmed that most of 
the macronuclear genome is composed of genic DNA, associated regulatory elements, 
and introns. Interestingly, about 2.3% of the genome is repetitive suggesting that a small 
subset of repetitive elements can escape DNA elimination during conjugation. However, 
most of the known micronuclear-limited sequences including many classes of 
transposable elements and IESs were absent, as predicted by decades of biochemical 
studies. No transposable elements were detected, underscoring the major role of the DNA 
elimination pathway in removing these deleterious classes of DNA elements from the 
transcriptionally permissive macronuclear compartment.  
The size of the macronuclear genome revealed that about 15-50% of the 
micronuclear genome is actively eliminated during conjugation. A recent effort in 
sequencing the micronuclear genome uncovered a new class of IESs and provided more 
micronuclear-limited sequences.184 However, due to the highly repetitive nature and very 
high AT content of the micronuclear genome, the sequencing reads were not able to 
support the assembly of entire chromosome, the total genome size was not determined, 
and to what extent the micronuclear genome was sequenced was not known.  
In collaboration with the Broad Institute, Dr. Robert S. Coyne (J. Craig Venter 
Institute, Rockville, MD) and Dr. Eduardo Orias (University of California, Santa 
Barbara), we sought to embark on a new micronuclear sequencing project with the goal 
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of assembling the entire genome. To address the complications above, we placed special 
emphasis on maximizing size of the sequencing libraries, providing high quality genomic 
DNA, and minimizing macronuclear DNA contamination. My contribution to this 
exciting project was to provide highly purified micronuclear DNA and perform some of 
the initial quality control experiments. The results of the project are summarized in 
“Tetrahymena Comparative Sequencing Project, Broad Institute of Harvard and MIT 
(http://www.broadinstitute.org/)”. Briefly, our findings showed that the micronuclear 
genome is approximately 158 megabases in length and about 22.08% GC rich. The 
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